WO2019147015A1 - Efficient synthesis method of c20 polyene bis(phosphonate) and carotene compound using same - Google Patents
Efficient synthesis method of c20 polyene bis(phosphonate) and carotene compound using same Download PDFInfo
- Publication number
- WO2019147015A1 WO2019147015A1 PCT/KR2019/000964 KR2019000964W WO2019147015A1 WO 2019147015 A1 WO2019147015 A1 WO 2019147015A1 KR 2019000964 W KR2019000964 W KR 2019000964W WO 2019147015 A1 WO2019147015 A1 WO 2019147015A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- structural formula
- compound represented
- formula
- carotene
- phosphonate
- Prior art date
Links
- 0 C*c(cc1)ccc1N(c1ccccc1)c1ccccc1 Chemical compound C*c(cc1)ccc1N(c1ccccc1)c1ccccc1 0.000 description 2
- VUQIEMOGCCDRND-UHFFFAOYSA-N CC(CCl)(C=C)O Chemical compound CC(CCl)(C=C)O VUQIEMOGCCDRND-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/02—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains containing only carbon and hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/04—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
- C07C403/10—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by etherified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/18—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/22—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Abstract
The present invention relates to an intermediate necessary for producing a carotene compound having excellent antioxidant activity with various aldehyde compounds in a single step reaction, a synthesis method thereof, and a synthesis method of various carotene compounds using the same. For this purpose, a novel tetraethyl (2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaen-1,16-diyl)bis(phosphonate) represented by structural formula 2 and diethyl (4-(benzo[d]thiazole-2-ylsulfonyl)-2-methyl-2-buten-1-yl) phosphonate of structural formula 5, and an efficient synthesis method thereof are proposed. When using C20 polyene bis(phosphonate) of structural formula 2, the carotene compound of various structures can be produced by a single step reaction with various aldehyde compounds, so that the reaction is efficient and simple.
Description
본 발명은 항산화제 또는 식용색소로 건강기능식품, 의약품, 및 화장품 원료로 사용될 수 있는 구조식 1로 표시되는 신규의 카로틴 화합물, 이를 효율적으로 합성하는데 적합한 구조식 2로 표시되는 신규의 C20 폴리엔 비스(포스포네이트) 화합물과 이의 합성방법, 및 이를 다양한 알데하이드 화합물과 반응시켜 상기 카로틴 화합물을 간편하게 합성하는 방법에 관한 것이다.The present invention is an antioxidant or a functional food as food coloring, medicines, and carotene compounds of novel represented by the following structural formula 1, which can be used as cosmetic ingredients, for efficiently synthesized in this appropriate formula 2 novel C 20 polyenes service represented by (Phosphonate) compound, a method for synthesizing the same, and a method for easily synthesizing the carotene compound by reacting it with various aldehyde compounds.
[구조식 1][Structural formula 1]
상기 식 중에서 R은 탄소수 5내지 20사이의 알킬, 아릴, 아르알킬(aralkyl), 및 헤테로아릴로 이루어진 군으로부터 선택될 수 있다. Wherein R may be selected from the group consisting of alkyl, aryl, aralkyl, and heteroaryl having 5 to 20 carbon atoms.
[구조식 2][Structural formula 2]
베타-카로틴을 비롯하여 라이코펜, 제아잔틴, 칸타잔틴, 아스타잔틴 등의 천연 카로틴 화합물들은 구조식 1로 표시되는 폴리엔 체인 구조를 공통으로 함유한다. 이들은 생물체 내에서 활성산소와 반응하여 이를 효율적으로 제거함으로써 항산화 효능을 보여주며, 광합성에서 엽록소와 함께 빛을 흡수하고 에너지를 전달하는데 중요한 역할을 담당하는 것으로 알려져 있다. 카로틴 화합물은 가축사료, 식품첨가제, 건강 보조식품, 의약품, 화장품 원료 등, 다양한 산업적 용도를 갖기 때문에 이들 카로틴 화합물을 효율적으로 합성하는 방법에 대한 연구가 계속 이어지고 있다. Natural carotene compounds such as lycopene, zeaxanthin, canthaxanthin, and astaxanthin, as well as beta-carotene, commonly contain the polyene chain structure represented by Structural Formula (1). They are known to have an antioxidative effect by reacting with active oxygen in living organisms and efficiently removing it, and it plays an important role in photosynthesis in absorbing light and transferring energy together with chlorophyll. Since carotene compounds have various industrial uses such as livestock feeds, food additives, health supplements, medicines, and cosmetic raw materials, studies on efficient synthesis of these carotene compounds are continuing.
카로틴 화합물을 합성하는 일반적인 방법은 아래 그림에서 나타낸 바와 같이 알데하이드 화합물 [구조식 A]를 아세톤과 반응시켜 알파,베타-불포화 케톤 화합물 [구조식 B]를 합성하고, 여기에 비닐기를 첨가하여 비닐-카르비놀 화합물 [구조식 C]를 합성한 다음, 산(HX)과 트리페닐포스핀(PPh3)을 순차적으로 반응시켜 구조식 3으로 표시되는 비티히 염을 제조하는 것을 기본으로 한다. 마지막으로, 2 당량의 비티히염[구조식 3]과 구조식 4로 표기되는 2,7-디메틸-2,4,6-옥타트리엔디알 1당량을 반응시켜 컨쥬에이트 폴리엔 체인을 함유하는 카로틴 화합물[구조식 1]을 합성하게 된다 (Angew. Chem. 1960, 72, 911-915; Angew. Chem. 1977, 89, 437-443).As a general method for synthesizing a carotene compound, an alpha, beta-unsaturated ketone compound [structural formula B] is synthesized by reacting an aldehyde compound [structural formula A] with acetone as shown in the following figure, (HX) and triphenylphosphine (PPh 3 ) are sequentially reacted to synthesize the compound [structural formula C], and then the biotite salt represented by the structural formula 3 is produced. Finally, two equivalents of biotite salt [structural formula 3] and one equivalent of 2,7-dimethyl-2,4,6-octatriendial represented by structural formula 4 were reacted to prepare a carotene compound containing a conjugated polyene chain [ (Angew. Chem. 1960, 72, 911-915; Angew. Chem. 1977, 89, 437-443).
상기 방법은 카로틴 화합물의 합성에 효율적으로 사용되고 있는 구조식 4의 C10 디알데하이드 화합물을 활용하는 것으로, 이와 결합하기 위하여 알데하이드 화합물 [구조식 A]로부터 여러 단계의 반응을 거쳐 구조식 3의 비티히 염을 제조하는 것을 필요로 한다. 즉, 구조식 1로 표시되는 다양한 카로틴 화합물들을 제조하기 위해서는 각각의 알데하이드 화합물 [구조식 A]로부터 여러 단계의 반응을 거쳐 구조식 3으로 표시되는 다양한 비티히 염을 제조하는 것이 필요하게 된다. The above method utilizes a C 10 dialdehyde compound of the structural formula 4 that is efficiently used in the synthesis of a carotene compound. In order to combine the C 10 dialdehyde compound with the aldehyde compound [structural formula A] . That is, in order to prepare the various carotene compounds represented by the structural formula 1, it is necessary to prepare various biotite salts represented by the structural formula 3 through various steps of reaction from the respective aldehyde compounds [structural formula A].
상기 식 중에서 R은 탄소수 5 내지 20 사이의 알킬, 아릴, 아르알킬 (aralkyl) 및 헤테로아릴로 이루어진 군으로부터 선택될 수 있다. Wherein R may be selected from the group consisting of alkyl, aryl, aralkyl and heteroaryl having between 5 and 20 carbon atoms.
상기와 같은 종래 방법은 각각의 알데하이드 화합물로부터 체인 확장 반응을 통해 비티히 염을 만들어 가는 긴 반응 단계를 거쳐야 하는 문제점이 있는 바, 다양한 구조의 카로틴 화합물을 각각의 알데하이드 화합물로부터 보다 간편하고 신속하게 제조할 수 있는 새로운 방법에 대한 필요성이 절실히 요구되고 있었다.In the conventional method as described above, there is a problem that a long reaction step is required to form a biotite salt from each aldehyde compound through a chain extension reaction. Thus, a carotene compound having various structures can be easily and rapidly prepared from each aldehyde compound There is a need for a new way to do this.
따라서 본 발명에서는, 구조식 1로 표시되는 다양한 카로틴 화합물을 보다 효율적으로 제조하기 위해서 알데하이드 화합물 [구조식 A]로부터 여러 반응단계를 거쳐 구조식 3의 다양한 비티히 염을 제조하는 대신에, 아래의 그림에서 나타낸 바와 같이 다양한 알데하이드 [구조식 A]와 직접 반응하여 바로 카로틴 화합물을 제공할 수 있는, 폴리엔 체인이 확장되고 포스핀 기를 함유하는 구조식 2와 같은 화합물을 제공하고자 한다. Therefore, in order to more efficiently prepare the various carotene compounds represented by the structural formula 1, it is possible to carry out various reaction steps from the aldehyde compound [structural formula A] to produce the various biotite salts of the structural formula 3, It is intended to provide a compound such as the structural formula 2 in which the polyene chain is extended and contains a phosphine group, which can directly react with various aldehydes [structural formula A] as described above to directly provide a carotene compound.
구조식 2의 폴리엔 화합물을 다양한 알데하이드 화합물 [구조식 A]와 반응시킬 경우 구조식 1의 다양한 카로틴 화합물을 단일 단계 반응으로 제조할 수 있기 때문에 반응이 효율적이고 경제적으로 진행될 뿐 아니라, 다양한 구조의 카로틴 화합물을 간편하고 신속하게 제조할 수 있다.When the polyene compound of formula 2 is reacted with various aldehyde compounds [formula A], the various carotene compounds of formula 1 can be prepared in a single step reaction, so that the reaction proceeds efficiently and economically, And can be manufactured easily and quickly.
상기 식 중에서 R은 탄소수 5내지 20사이의 알킬, 아릴, 아르알킬(arakyl), 및 헤테로아릴로 이루어진 군으로부터 선택될 수 있다. Wherein R may be selected from the group consisting of alkyl, aryl, aralkyl, and heteroaryl having 5 to 20 carbon atoms.
본 발명에서는 비티히 반응을 이용하는 기존의 방법에 따라 구조식 4로 표시되는 2,7-디메틸-2,4,6-옥타트리엔디알을 이용하여 구조식 1로 표시되는 다양한 구조의 카로틴 화합물을 제조하는데 있어서, 알데하이드 화합물 [구조식 A]로부터 여러 단계의 반응을 거쳐 체인이 확장되고 포스핀기를 함유하는 구조식 3의 다양한 비티히 염을 만들어야 하는 문제점을 해결하고자 한다. 이를 위하여 다양한 알데하이드 화합물 [구조식 A]와 단일 단계의 반응으로 신속하고 간편하게 구조식 1로 표시되는 다양한 구조의 카로틴 화합물을 제조하는데 필요한 신규의 폴리엔 화합물과 이의 제조 방법, 및 이를 이용하여 다양한 구조의 카로틴 화합물을 간편하고 효율적으로 합성하는 방법을 제안하고자 한다.In the present invention, a carotene compound having various structures represented by the structural formula 1 is prepared by using 2,7-dimethyl-2,4,6-octatrienediar represented by the structural formula 4 according to the conventional method using the Biathyer reaction To solve the problem of making various biotite salts of the structural formula 3 containing a phosphine group by extending the chain through an aldehyde compound [structural formula A] in several steps. For this purpose, a novel polyene compound, which is required for the production of a carotene compound having various structures represented by the structural formula 1 by a single step reaction with various aldehyde compounds [structural formula A], a method for producing the same, We propose a simple and efficient method for synthesizing the compounds.
상기의 문제를 해결하기 위하여, 본 발명에서는 다양한 알데하이드 화합물 [구조식 A]로부터 다양한 카로틴 화합물을 단일 단계의 반응으로 간편하고 효율적으로 합성하는데 필요한 구조식 2로 표시되는 신규의 C20 폴리엔 비스(포스포네이트) 화합물과 이의 제조 방법, 및 이를 이용하여 구조식 1로 표시되는 다양한 카로틴 화합물과 이들의 효율적인 합성방법을 제공한다.In order to solve the above problems, the present invention provides a novel C 20 polyenbis represented by the structural formula 2 required for the simple and efficient synthesis of various carotene compounds from various aldehyde compounds (structural formula A) Nate) compound, a method for producing the same, and various carotene compounds represented by the structural formula 1 using the same, and a method for efficiently synthesizing the same.
본 발명에서 이루고자하는 첫 번째 기술적인 과제는 구조식 2로 표시되는 신규의 테트라에틸 (2,6,11,15-테트라메틸헥사데카-2,4,6,8,10,12,14-헵타엔-1,16-디일)비스(포스포네이트)를 제공하는 것이다. The first technical object of the present invention is to provide a novel tetraethyl (2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaene -1, 16-diyl) bis (phosphonate).
[구조식 2][Structural formula 2]
본 발명에서 이루고자하는 두 번째 기술적인 과제는 구조식 2의 테트라에틸 (2,6,11,15-테트라메틸헥사데카-2,4,6,8,10,12,14-헵타엔-1,16-디일)비스(포스포네이트)를 제조하는데 필요한 구조식 5로 표시된는 신규의 디에틸 (4-(벤조[d]티아졸-2-일설포닐)-2-메틸-2-부텐-1-일)포스포네이트를 제공하는 것이다.A second technical objective of the present invention is to provide a process for the preparation of tetraethyl (2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaen-1,16 (Benzo [ d ] thiazol-2-ylsulfonyl) -2-methyl-2-buten-l-yl) -bis (phosphonate) To provide a phosphonate.
[구조식 5][Structural Formula 5]
본 발명에서 이루고자 하는 세 번째 기술적인 과제는 구조식 5로 표기되는 신규의 디에틸 (4-(벤조[d]티아졸-2-일설포닐)-2-메틸-2-부텐-1-일)포스포네이트의 제조방법을 제공하는 것이다.A third technical object of the present invention is to provide a novel diethyl (4- (benzo [ d ] thiazole-2-ylsulfonyl) -2-methyl- And to provide a method for producing a phenate.
상기 방법은 (a) 이소프렌으로부터 구조식 D로 표시되는 클로로하이드린 화합물을 제조하는 단계; The method comprises: (a) preparing a chlorohydrin compound represented by formula D from isoprene;
(b) 구조식 D로 표시되는 알릴릭 알콜의 브롬화 반응으로 구조식 E로 표시되는 알릴릭디할라이드 화합물을 제조하는 단계; (b) a step of brominating an allylic alcohol represented by the structural formula D to produce an allyl halide compound represented by the structural formula E;
(c) 구조식 E로 표시되는 알릴릭디할라이드 화합물과 2-머켑토벤조티아졸을 반응시켜 구조식 F로 표시되는 클로로알릴릭 설파이드 화합물을 제조하는 단계; (c) reacting the allyl halide compound represented by the structural formula E with 2-mercaptobenzothiazole to prepare a chloroallylic sulfide compound represented by the structural formula F;
(d) 구조식 F로 표시되는 클로로알릴릭 설파이드 화합물의 산화반응에 의해 구조식 G로 표시되는 클로로알릴릭 설폰 화합물을 제조하는 단계; 및 (d) preparing a chloroallylic sulfone compound represented by Structural Formula G by oxidation reaction of chloroallylic sulfide compound represented by Structural Formula F; And
(e) 구조식 G로 표시되는 화합물의 알릴릭 클로라이드와 트리에틸포스파이트 [P(OEt)3]와의 아르부조프(Arbuzov) 반응에 의하여 디에틸 포스포네이트기를 함유하는 구조식 5로 표시되는 신규의 디에틸 (4-(벤조[d]티아졸-2-일설포닐)-2-메틸-2-부텐-1-일)포스포네이트의 제조방법을 제공하는 것이다.(e) A novel compound represented by Structural Formula 5 containing a diethylphosphonate group by Arbuzov reaction between allylic chloride of the compound represented by Structural Formula G and triethylphosphite [P (OEt) 3 ] (Benzo [ d ] thiazole-2-ylsulfonyl) -2-methyl-2-buten-1-yl) phosphonate.
상기 (a)단계에서 이소프렌의 클로로하이드린 형성반응은 수용액에서 N-chlorosuccinimide (NCS)를 이용하여 진행할 수 있으며, 이 때 DMF와 같은 극성 유기용매를 부피비 10% 정도로 섞어주는 것이 바람직하다.The chlorohydrin formation reaction of isoprene in the step (a) can be carried out using N-chlorosuccinimide (NCS) in an aqueous solution, and it is preferable to mix a polar organic solvent such as DMF at a volume ratio of about 10%.
상기 (b)단계에서 알릴릭 알콜의 브롬화 반응은 PBr3를 이용하여 0 ℃내지는 실온에서 진행하며, 알릴릭 재배열 반응을 위하여 할로겐화 구리 (Cu-X)를 촉매로 더해 주는 것이 바람직하다. In the step (b), the bromination reaction of the allylic alcohol proceeds at 0 ° C to room temperature using PBr 3 , and copper (Cu-X) is preferably added as a catalyst for the allylic rearrangement reaction.
상기 (c)단계에서 구조식 E로 표시되는 화합물의 알릴릭브로마이드와 2-머켑토벤조티아졸의 친핵 치환반응은 K2CO3를 염기로 아세톤 용매에서 진행하는 것이 위치 선택적인 면에서 바람직하다.In the step (c), the nucleophilic substitution reaction of the allylic bromide and the 2-mercaptobenzothiazole of the compound represented by the structural formula E is preferable in terms of the position-selective reaction of K 2 CO 3 as a base in an acetone solvent.
또한 (c)단계에서 구조식 E로 표시되는 알랄릭디할라이드 화합물과 2-머켑토벤조티아졸은 1:1의 당량비로 반응시킬 수 있다. 여기서 2-머켑토벤조티아졸은 알릴릭브로마이드기와 반응할 수 있다.In step (c), the allylic halide compound represented by the structural formula E and the 2-mercaptobenzothiazole may be reacted in an equivalent ratio of 1: 1. Wherein the 2-mercaptobenzothiazole can react with an allylic bromide group.
상기 (d)단계의 설파이드기의 설폰으로의 산화반응은 H2O2와 다양한 금속촉매를 이용하거나, peracetic acid, MCPBA (meta-chloroperbenzoic acid), mono perphthalic acid 등의 유기 산화제를 이용하여 진행할 수 있다.The oxidation of the sulfide group to sulfone in step (d) can be carried out using H 2 O 2 and various metal catalysts or by using an organic oxidizing agent such as peracetic acid, MCPBA (meta-chloroperbenzoic acid) or mono perphthalic acid have.
상기 (e)단계에서 아르부조프(Arbuzov) 반응은 알릴릭 클로라이드를 핀켈슈타인(Finkelstein) 반응 (NaI, acetone)으로 알릴릭아이오다이드로 활성화시켜 트리에틸포스파이트와 반응시켜 진행하는 것이 바람직하다. In the step (e), the Arbuzov reaction is preferably carried out by activating allylic chloride with allylic iodide in a Finkelstein reaction (NaI, acetone) and reacting with triethylphosphite.
본 발명에서 이루고자 하는 네 번째 기술적인 과제는 구조식 5로 표시되는 디에틸 (4-(벤조[d]티아졸-2-일설포닐)-2-메틸-2-부텐-1-일)포스포네이트와 구조식 4의 2,7-디메틸-2,4,6-옥타트리엔디알을 반응시켜 구조식 2로 표시되는 신규의 테트라에틸 (2,6,11,15-테트라메틸헥사데카-2,4,6,8,10,12,14-헵타엔-1,16-디일)비스(포스포네이트)의 제조방법을 제공하는 것이다.A fourth technical object of the present invention is to provide a process for producing a diethyl (4- (benzo [ d ] thiazole-2-ylsulfonyl) -2-methyl- (2,6,11,15-tetramethylhexadeca-2,4-dione represented by the structural formula 2) by reacting 2,7-dimethyl-2,4,6- 6,8,10,12,14-heptaen-1,16-diyl) bis (phosphonate).
상기 반응에서 구조식 5로 표시되는 화합물과 구조식 4로 표시되는 화합물은 2:1의 당량비로 반응할 수 있다.In the above reaction, the compound represented by Formula 5 and the compound represented by Formula 4 can be reacted at an equivalent ratio of 2: 1.
상기 반응은 THF, DME 등의 aprotic solvent 하에서 NaHMDS 또는 KHMDS 등의 염기를 사용하여 -78 ℃내지 0 ℃의 저온에서 진행하는 것이 바람직하다.The reaction is preferably carried out at a low temperature of -78 ° C to 0 ° C using a base such as NaHMDS or KHMDS in an aprotic solvent such as THF or DME.
본 발명에서 이루고자하는 다섯 번째 기술적인 과제는 구조식 2의 C20 폴리엔 비스(포스포네이트) 화합물을 다양한 알데하이드 화합물 [구조식 A]와 반응시켜 구조식 1의 다양한 카로틴 화합물의 제조 방법을 제공하는 것이다. A fifth technical objective of the present invention is to provide a process for preparing various carotene compounds of formula 1 by reacting a C 20 polyenes (phosphonate) compound of formula 2 with various aldehyde compounds [formula A].
상기 식 중에서 R은 탄소수 5내지 20사이의 알킬, 아릴, 아르알킬(aralkyl), 및 헤테로아릴로 이루어진 군으로부터 선택될 수 있다. Wherein R may be selected from the group consisting of alkyl, aryl, aralkyl, and heteroaryl having 5 to 20 carbon atoms.
상기 알킬, 아릴 또는 아르알킬(aralkyl), 및 헤테로아릴은 치환기를 가질 수 있다.The above-mentioned alkyl, aryl or aralkyl, and heteroaryl may have a substituent.
상기 반응에서 구조식 A로 표시되는 화합물과 구조식 2로 표시되는 화합물은 2:1의 당량비로 반응할 수 있다.In the above reaction, the compound represented by the structural formula A and the compound represented by the structural formula 2 can be reacted at an equivalent ratio of 2: 1.
상기 방법은 알코올과 톨루엔 혼합 용매에서 메탈 알콕사이드 염기를 이용하여 100 ℃ 이상의 온도에서 환류 가열하여 진행하는 것이 바람직하다. The above process is preferably carried out by heating the mixture at a temperature of 100 ° C or higher using a metal alkoxide base in a mixed solvent of alcohol and toluene.
본 발명에서 이루고자하는 마지막 여섯 번째 기술적인 과제는 구조식 2로 표시되는 C20 폴리엔 비스(포스포네이트) 화합물과 다양한 알데하이드 화합물 [구조식 A]의 단일 단계 반응으로 효율적으로 제조되는 하기의 구조식 1-1 부터 구조식 1-9 까지로 표시되는 신규의 다양한 카로틴 화합물을 제공하는 것이다. A sixth and final technical objective of the present invention is to provide a process for the preparation of a compound of formula (I), which is efficiently produced by a single step reaction of a C 20 polyenes (phosphonate) compound of formula 2 with various aldehyde compounds [formula A] 1 to < RTI ID = 0.0 > 1-9. ≪ / RTI >
[구조식 1-1][Structural formula 1-1]
[구조식 1-2][Structural formula 1-2]
[구조식 1-3][Structural Formula 1-3]
[구조식 1-4][Structural Formula 1-4]
[구조식 1-5][Structural Formula 1-5]
[구조식 1-6][Structural formula 1-6]
[구조식 1-7][Structural formula 1-7]
[구조식 1-8][Structural formula 1-8]
[구조식 1-9][Structural formula 1-9]
본 발명에 따라 신규 제조된 구조식 2의 테트라에틸 (2,6,11,15-테트라메틸헥사데카-2,4,6,8,10,12,14-헵타엔-1,16-디일)비스(포스포네이트)는 다양한 알데하이드 화합물 [구조식 A]와 단일 단계 반응으로 구조식 1로 표시되는 다양한 구조의 카로틴 화합물을 효율적이고 간편하게 제공하게 된다. Tetraethyl (2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaen-1,16-diyl) bis (Phosphonates) efficiently and easily provide various types of carotene compounds represented by the structural formula 1 in a single step reaction with various aldehyde compounds [structural formula A].
본 발명에 따라 신규 제조된 구조식 5의 디에틸 (4-(벤조[d]티아졸-2-일설포닐)-2-메틸-2-부텐-1-일)포스포네이트는 구조식 4의 2,7-디메틸-2,4,6-옥타트리엔디알과 단일 단계 반응으로 카로틴 화합물의 합성에 사용될 수 있는 상기 구조식 2로 표시되는 테트라에틸 (2,6,11,15-테트라메틸헥사데카-2,4,6,8,10,12,14-헵타엔-1,16-디일)비스(포스포네이트)를 효율적이고 간편하게 제공하게 된다. The diethyl (4- (benzo [ d ] thiazol-2-ylsulfonyl) -2-methyl-2-buten-1-yl) phosphonate of the newly prepared formula 5 has the structure 2, (2,6,11,15-tetramethylhexadec-2-ene) represented by the above structural formula 2 which can be used in the synthesis of a carotene compound by a single step reaction with 7-dimethyl- , 4,6,8,10,12,14-heptaen-1,16-diyl) bis (phosphonate) efficiently and easily.
본 발명에 따라 제조된 구조식 1-1부터 1-9의 신규 카로틴 화합물은 활성산소 및 라디칼들과 반응하여 항산화 능력을 보이는 물질들로서 가축사료, 식품첨가제, 건강 보조식품, 의약품, 화장품 원료 등, 다양한 산업적 용도를 갖게 되는 물질이다. The novel carotene compounds of the structural formulas 1-1 to 1-9 prepared according to the present invention exhibit antioxidative ability by reacting with active oxygen and radicals and can be used for a variety of purposes including livestock feeds, food additives, health supplements, medicines, It is a substance that is used for industrial purposes.
이하, 실시예를 통하여 본 발명에 대하여 더욱 구체적으로 설명한다. 이는 본 발명이 속하는 기술 분야의 통상의 기술자에게 본 발명이 충분히 전달될 수 있도록 하기 위하여 제공되는 것이므로 이하의 실시예에 의하여 본 발명이 제한되어서는 안 된다.Hereinafter, the present invention will be described more specifically by way of examples. It is to be understood that the same is by way of illustration and example only and is not to be construed as limiting the present invention.
실시예 1. [구조식D]로 표시되는 화합물 Example 1. A compound represented by [Structural formula D]
1-Chloro-2-methylbut-3-en-2-ol.1-Chloro-2-methylbut-3-en-2-ol.
이소프렌(24.0 mL, 0.24 mol)과 N-클로로숙신이미드(NCS, 26.7 g, 0.20 mol)를 증류수(100 mL)와 DMF(25 mL)의 혼합 용액에 가한 다음 냉각장치를 설치하여 40 ℃ 온도에서 20 시간 동안 교반한다. 반응 결과물을 실온으로 식힌 다음 디에틸에테르로 추출하고, 무수 Na2SO4로 건조시킨 다음 거름종이로 거르고 여액을 감압 하에 농축하여 무색 액체의 클로로하이드린 [구조식 D](18.8 g, 0.16 mol)를 78%의 수율로 얻을 수 있었다. Data for [구조식 D]: [Rf = 0.44 (4:1 hexane:EtOAc)]; 1H NMR δ = 1.38 (s, 3H), 2.17 (br s, 1H), 3.53 (A of ABq, J
AB = 10.8 Hz, 1H), 3.57 (B of ABq, J
AB = 10.8 Hz, 1H), 5.21 (dd, J = 10.7, 1.0 Hz, 1H), 5.38 (dd, J = 17.3, 1.0 Hz, 1H), 5.92 (dd, J = 17.3, 10.7 Hz, 1H) ppm; 13C NMR δ = 25.3, 54.0, 72.5, 114.7, 141.9 ppm.(24.0 mL, 0.24 mol) and N -chlorosuccinimide (NCS, 26.7 g, 0.20 mol) were added to a mixed solution of distilled water (100 mL) and DMF (25 mL) Lt; / RTI > for 20 hours. The reaction product was cooled to room temperature, extracted with diethyl ether, dried over anhydrous Na 2 SO 4 , filtered through filter paper, and the filtrate was concentrated under reduced pressure to obtain a colorless liquid chlorohydrin [formula D] (18.8 g, 0.16 mol) Was obtained in a yield of 78%. Data for [structural formula D]: [R f = 0.44 (4: 1 hexane: EtOAc)]; 1 H NMR δ = 1.38 (s , 3H), 2.17 (br s, 1H), 3.53 (A of ABq, J AB = 10.8 Hz, 1H), 3.57 (B of ABq, J AB = 10.8 Hz, 1H), (Dd, J = 10.7, 1.0 Hz, 1H), 5.38 (dd, J = 17.3, 1.0 Hz, 1H), 5.92 (dd, J = 17.3, 10.7 Hz, 1H) ppm; 13 C NMR? = 25.3, 54.0, 72.5, 114.7, 141.9 ppm.
실시예 2. [구조식 E]로 표시되는 화합물 Example 2. A compound represented by the structural formula E
4-Bromo-1-chloro-2-methylbut-2-ene.4-Bromo-1-chloro-2-methylbut-2-ene.
아르곤 대기 하에서 클로로하이드린 [구조식 D](13.8 g, 0.12 mol)를 벤젠(80 mL)와 THF(10 mL)에 녹인 다음, 0 ℃에서 CuI(220 mg, 1.15 mmol)와 PBr3(4.5 mL, 46.03 mmol)를 순차적으로 더한다. 상기 반응 혼합물을 0 ℃에서 2.5 시간 동안 교반한 다음, 실리카겔 패드를 이용하여 거르고, 부피비 3:1의 디에틸에테르/헥산 혼합 용매를 이용하여 씻는다. 상기 여과액을 감압 농축하여 노란색 액체의 4-클로로알릴릭브로마이드 [구조식 E](19.50 g. 0.11 mol, E/Z = 5:1)를 92%의 수율로 얻을 수 있다. Data for [구조식 E]: Rf = 0.73 (4:1 hexane:EtOAc); 1H NMR δ = 1.85 (s, 3H), 3.98 (dd, J = 8.3, 0.9 Hz, 2H), 4.03 (s, 2H), 5.87 (dt, J
t = 8.3, J
d = 0.9 Hz, 1H) ppm; 13C NMR δ = 14.1, 27.3, 50.6, 125.3, 137.8 ppm. (13.8 g, 0.12 mol) was dissolved in benzene (80 mL) and THF (10 mL) under argon atmosphere and then CuI (220 mg, 1.15 mmol) and PBr 3 , 46.03 mmol) were added sequentially. The reaction mixture was stirred at 0 ° C for 2.5 hours, then filtered through a pad of silica gel and washed with a 3: 1 by volume mixed solvent of diethyl ether / hexane. The filtrate was concentrated under reduced pressure to obtain a yellow liquid of 4-chloroallylic bromide [structural formula E] (19.50 g, 0.11 mol, E / Z = 5: 1) in a yield of 92%. Data for [formula E]: Rf = 0.73 (4: 1 hexane: EtOAc); 1 H NMR δ = 1.85 (s , 3H), 3.98 (dd, J = 8.3, 0.9 Hz, 2H), 4.03 (s, 2H), 5.87 (dt, J t = 8.3, J d = 0.9 Hz, 1H) ppm; 13 C NMR? = 14.1, 27.3, 50.6, 125.3, 137.8 ppm.
실시예 3. [구조식 F]로 표시되는 화합물 Example 3. Synthesis of Compound Represented by Structural Formula F
2-((4-Chloro-3-methylbut-2-en-1-yl)thio)benzo[d]thiazole.2 - ((4-Chloro-3-methylbut-2-en-1-yl) thio) benzo [d] thiazole.
아르곤 대기하에서 4-클로로알릴릭 브로마이드 [구조식 E](19.49 g, 0.106 mol)를 아세톤 (100 mL)에 녹인 뒤, 0 ℃ 온도에서 2-머켑토벤조티아졸(16.15 g, 96.57 mmol)과 무수 K2CO3(20.02 g, 0.145 mol)를 순차적으로 더한다. 상기 반응 혼합물을 0 ℃의 온도에서 2 시간 동안 교반한 뒤, 실온으로 올려 11시간 동안 잘 교반 하여 준다. 반응 결과물을 디에틸에테르로 묽히고, 물과 10% 탄산수소나트륨 용액 및 브라인 용액으로 씻는다. 수용액을 다시 디에틸에테르로 추출하고, 유기층을 합하여 무수 Na2SO4로 건조시키고, 거름종이로 거른 뒤 여액을 감압 하에 농축하여 노란색 액체의 클로로알릴릭 설파이드 화합물 [구조식 F] (27.05 g, 0.100 mol, E:Z = 7:1)를 95%의 수율로 얻을 수 있었다. Data for [구조식 F]: Rf = 0.61 (1:4 EtOAc/hexane); 1HNMR δ = 1.90 (s, 3H), 4.02 (s, 2H), 4.03 (d, J = 7.6 Hz, 2H), 5.82 (t, J = 7.6 Hz, 1H), 7.30 (t, J = 8.0 Hz, 1H), 7.42 (t, J = 8.0 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.87 (d, J = 8.0 Hz, 1H) ppm; 13CNMR δ = 14.4, 30.9, 51.0, 120.8, 121.4, 123.7, 124.1, 125.9, 135.2, 136.7, 153.0, 165.8 ppm; IR (KBr) 2989, 1473, 1436, 1321, 1275, 1243, 1078, 1004, 871, 765, 687, 724 cm-1; HRMS (CI) calcd for C12H13ClNS2 270.0178, found 270.0180.(19.49 g, 0.106 mol) was dissolved in acetone (100 mL) under an argon atmosphere and then 2-mercaptobenzothiazole (16.15 g, 96.57 mmol) and anhydrous K 2 CO 3 (20.02 g, 0.145 mol) was added sequentially. The reaction mixture was stirred at a temperature of 0 ° C for 2 hours, then allowed to warm to room temperature and stirred well for 11 hours. Dilute the reaction product with diethyl ether, wash with water, 10% sodium hydrogencarbonate solution and brine solution. The aqueous solution was extracted again with diethyl ether, and the combined organic layers were dried over anhydrous Na 2 SO 4 , filtered through filter paper and the filtrate was concentrated under reduced pressure to obtain a chloroallylic sulfide compound [structural formula F] (27.05 g, 0.100 mol, E : Z = 7: 1) was obtained in a yield of 95%. Data for [formula F]: Rf = 0.61 (1: 4 EtOAc / hexane); 1 HNMR δ = 1.90 (s, 3H), 4.02 (s, 2H), 4.03 (d, J = 7.6 Hz, 2H), 5.82 (t, J = 7.6 Hz, 1H), 7.30 (t, J = 8.0 Hz 8.0 Hz, 1H), 7.42 (t, J = 8.0 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.87 (d, J = 8.0 Hz, 1H) ppm; 13 CNMR? = 14.4, 30.9, 51.0, 120.8, 121.4, 123.7, 124.1, 125.9, 135.2, 136.7, 153.0, 165.8 ppm; IR (KBr) 2989, 1473, 1436, 1321, 1275, 1243, 1078, 1004, 871, 765, 687, 724 cm < -1 & gt ;; HRMS (CI) calcd for C 12 H 13 ClN 2 270.0178, found 270.0180.
실시예 4. [구조식 G]로 표시되는 화합물 Example 4. A compound represented by the structural formula G
2-((4-Chloro-3-methylbut-2-en-1-yl)sulfonyl)benzo[d]thiazole.2 - ((4-Chloro-3-methylbut-2-en-1-yl) sulfonyl) benzo [d] thiazole.
아르곤 대기하에서 Urea-H2O2(44.35 g, 0.47 mmol)와 무수프탈산(38.90 g, 0.236 mol)에 아세토니트릴(150 mL) 더한다. 상기 혼합물을 실온에서 1시간 반 동안 교반하여 무색의 모노-퍼프탈산 용액을 얻는다. 상기 용액에 4-클로로알릴릭설파이드 [구조식 F](21.20 g, 78.57 mmol)를 CH2Cl2 (10 mL)에 녹여 천천히 가한다음 실온에서 12시간 동안 교반한다. 반응 결과 흰색의 고형물을 CH2Cl2로 묽히고 거름종이로 거른다. 여과액을 물로 씻은 다음 무수 Na2SO4로 건조시키고, 거름종이로 거른 다음 여액을 감압 하에 농축하여 아이보리색 고체를 얻을 수 있었다. 이를 메탄올을 이용한 재결정의 방법으로 정제하여 흰색 고체의 4-클로로알릴릭 설폰 [구조식 G](17.15 g, 56.82 mmol)를 72%의 수율로 얻을 수 있었다. Data for [구조식 G]: Rf = 0.22 (1:4 EtOAc/hexane); 1HNMR δ = 1.70 (s, 3H), 3.95 (s, 2H), 4.29 (d, J = 7.6 Hz, 2H), 5.66 (t, J = 7.6 Hz, 1H), 7.61 (t, J = 8.0 Hz, 1H), 7.66 (t, J = 8.0 Hz, 1H), 8.02 (d, J = 8.0 Hz, 1H), 8.23 (d, J = 8.0 Hz, 1H) ppm; 13CNMR δ = 14.0, 49.1, 53.4, 113.1, 121.4, 124.5, 126.8, 127.2, 136.1, 142.3, 151.7, 165.8 ppm; IR (KBr) 2986, 2924, 1558, 1473, 1398, 1328, 1257, 1140, 1088, 1037, 910, 868, 765, 736, 689 cm-1; HRMS (CI) calcd for C12H13ClNO2S2 302.0076, found 302.0075.Acetonitrile (150 mL) is added to Urea-H 2 O 2 (44.35 g, 0.47 mmol) and anhydrous phthalic acid (38.90 g, 0.236 mol) under an argon atmosphere. The mixture was stirred at room temperature for 1.5 hours to obtain a colorless mono-phthalic acid solution. 4-Chloroallyl sulfide [formula F] (21.20 g, 78.57 mmol) is dissolved in CH 2 Cl 2 (10 mL) and the mixture is stirred at room temperature for 12 hours. As a result, the white solid was diluted with CH 2 Cl 2 and filtered with a filter paper. The filtrate was washed with water, dried over anhydrous Na 2 SO 4 , filtered through filter paper, and the filtrate was concentrated under reduced pressure to obtain an ivory solid. This was purified by recrystallization using methanol to obtain 4-chloroallyl sulfone [formula G] (17.15 g, 56.82 mmol) as a white solid in 72% yield. Data for [structural formula G]: Rf = 0.22 (1: 4 EtOAc / hexane); 1 HNMR δ = 1.70 (s, 3H), 3.95 (s, 2H), 4.29 (d, J = 7.6 Hz, 2H), 5.66 (t, J = 7.6 Hz, 1H), 7.61 (t, J = 8.0 Hz 8.0 Hz, 1H), 7.66 (t, J = 8.0 Hz, 1H), 8.02 (d, J = 8.0 Hz, 1H), 8.23 (d, J = 8.0 Hz, 1H) ppm; 13 CNMR? = 14.0, 49.1, 53.4, 113.1, 121.4, 124.5, 126.8, 127.2, 136.1, 142.3, 151.7, 165.8 ppm; IR (KBr) 2986, 2924, 1558, 1473, 1398, 1328, 1257, 1140, 1088, 1037, 910, 868, 765, 736, 689 cm -1 ; HRMS (CI) calcd for C 12 H 13 ClNO 2 S 2 302.0076, found 302.0075.
실시예 5. [구조식 5]로 표시되는 화합물 Example 5. A compound represented by the structural formula 5
Diethyl (4-(benzo[d]thiazol-2-ylsulfonyl)-2-methylbut-2-en-1-yl)phosphonate.Diethyl (4- (benzo [d] thiazol-2-ylsulfonyl) -2-methylbut-2-en-1-yl) phosphonate.
4-클로로알릴릭 설폰 [구조식 G](12.81 g, 42.44 mmol)를 아세톤(120 mL)에 녹인 뒤 NaI(9.54 g, 63.66 mmol)를 더한다. 상기 반응 혼합물을 아르곤 대기하의 실온에서 8시간 동안 잘 교반한 다음 디에틸에테르로 묽히고, 물로 씻은 다음 무수 Na2SO4로 건조시키고, 여과한 뒤 감압 농축하여 노란색 고체를 얻을 수 있었다. 이를 톨루엔(100 mL)에 녹이고 트리에틸 포스파이트(10.9 mL, 63.66 mmol)를 더한 뒤 아르곤 대기 하에서 12시간 동안 용매의 끓는점까지 환류 교반한다. 실온으로 식힌 뒤 대부분의 용매를 감압하에 제거하고 남은 액체를 실리카겔 컬럼크로마토그래피의 방법으로 정제하여(30%-100% acetone/hexane) 오렌지색 액체의 구조식 5로 표시되는 디에틸 포스포네이트(12.95 g, 32.1 mmol, E/Z = 4:1)를 76%의 수율로 얻을 수 있었다. Data for [구조식 5]: Rf = 0.25 (100% EtOAc); 0.32 (50% acetone/hexane); 1H NMR δ = 1.26 (t, J = 7.2 Hz, 6H), 1.78 (d, J = 2.8 Hz, 3H), 2.59 (d, J = 22.4 Hz, 2H), 4.04 (dq, J
d = 7.6, J
q = 7.2 Hz, 4H), 4.30 (dd, J = 7.6, 3.6 Hz, 2H), 5.45 (dt, J
d = 5.6, J
t = 7.6 Hz, 1H), 7.60 (t, J = 7.6 Hz, 1H), 7.65 (t, J = 7.6 Hz, 1H), 8.02 (d, J = 8.0 Hz, 1H), 8.23 (d, J = 8.0 Hz, 1H) ppm; 13CNMR δ = 16.3 (d, J = 6.0 Hz), 18.0 (d, J = 2.2 Hz), 37.1 (d, J = 136.9 Hz), 54.5 (d, J = 3.0 Hz), 61.9 (d, J = 6.7 Hz), 113.3 (d, J = 12.6 Hz), 122.3, 125.3, 127.6, 128.0, 136.9, 139.0 (d, J = 11.1 Hz), 152.6, 165.6 ppm; IR (KBr) 3001, 2920, 1741, 1471, 1395, 1338, 1249, 1154, 1017, 969, 855, 770, 732, 690, 637 cm-1; HRMS (CI) calcd for C16H23NO5PS2 404.0755, found 404.0759.4-Chloroallyl sulfone [formula G] (12.81 g, 42.44 mmol) is dissolved in acetone (120 mL) and NaI (9.54 g, 63.66 mmol) is added. Higo dilute the reaction mixture to a room temperature in an argon atmosphere under good stirring for 8 hours, and then diethyl ether, washed with water and then dried over anhydrous Na 2 SO 4, and filtered and concentrated under reduced pressure, there was obtained a yellow solid. This was dissolved in toluene (100 mL), triethyl phosphite (10.9 mL, 63.66 mmol) was added, and the mixture was refluxed for 12 hours to the boiling point of the solvent under an argon atmosphere. After cooling to room temperature, most of the solvent was removed under reduced pressure, and the remaining liquid was purified by silica gel column chromatography (30% -100% acetone / hexane) to give diethylphosphonate , 32.1 mmol, E / Z = 4: 1) was obtained in a yield of 76%. Data for [formula 5]: Rf = 0.25 (100% EtOAc); 0.32 (50% acetone / hexane); 1 H NMR δ = 1.26 (t , J = 7.2 Hz, 6H), 1.78 (d, J = 2.8 Hz, 3H), 2.59 (d, J = 22.4 Hz, 2H), 4.04 (dq, J d = 7.6, J q = 7.2 Hz, 4H) , 4.30 (dd, J = 7.6, 3.6 Hz, 2H), 5.45 (dt, J d = 5.6, J t = 7.6 Hz, 1H), 7.60 (t, J = 7.6 Hz, 1H), 7.65 (t, J = 7.6 Hz, 1H), 8.02 (d, J = 8.0 Hz, 1H), 8.23 (d, J = 8.0 Hz, 1H) ppm; 13 CNMR δ = 16.3 (d, J = 6.0 Hz), 18.0 (d, J = 2.2 Hz), 37.1 (d, J = 136.9 Hz), 54.5 (d, J = 3.0 Hz), 61.9 (d, J = 6.7 Hz), 113.3 (d, J = 12.6 Hz), 122.3, 125.3, 127.6, 128.0, 136.9, 139.0 (d, J = 11.1 Hz), 152.6, 165.6 ppm; IR (KBr) 3001, 2920, 1741, 1471, 1395, 1338, 1249, 1154, 1017, 969, 855, 770, 732, 690, 637 cm -1 ; HRMS (CI) calcd for C 16 H 23 NO 5 PS 2 404.0755, found 404.0759.
실시예 6. [구조식 2]로 표시되는 화합물 Example 6. A compound represented by the structural formula 2
Tetraethyl (2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaene-1,16-diyl)bis(phosphonate)Tetraethyl (2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaene-1,16-diyl) bis (phosphonate)
아르곤 대기하에서 구조식 5의 BT-설포닐 포스포네이트(1.46 g, 3.62 mmol, 2.9 당량)와 구조식 4의 2,7-디메틸-2,4,6-옥타트리엔디알(198 mg, 1.21 mmol, 1 당량)을 THF(36 mL)에 녹인 뒤 -78 ℃로 냉각한다. 여기에 1M NaHMDS(4.0 mL, 4.0 mmol, 3.1 당량)를 15분 동안 천천히 더한다. 연노랑색의 용액이 NaHMDS가 더해짐에 따라 서서히 붉은색으로 변한다. 상기 혼합물을 -78 ℃에서 1시간 반 동안 교반하고 0 ℃에서 3시간 반 동안 교반한 다음 10% 염화암모늄 용액으로 반응을 종결시킨다. 반응 혼합물을 에틸아세테이트로 추출하고, 브라인으로 씻은 다음 무수 탄산칼륨으로 건조하고, 필터한 뒤, 여액을 감압 하에 농축시켜 붉은색 액체 1.52 g을 얻는다. 이를 실리카겔 컬럼크로마토그라피의 방법으로 정제하여(30%-100% acetone/hexane) 오렌지색 고체의 구조식 2로 표시되는 테트라에틸 비스(포스포네이트)(422 mg, 0.78 mmol, all-E/Z = 6:1)를 64%의 수율로 얻을 수 있었다. Data for [구조식 2]: Rf = 0.19 (50%acetone/hexane); 1H NMR δ = 1.31 (t, J = 7.2 Hz, 12H), 1.94 (s, 6H), 1.96 (d, J = 4.4 Hz, 6H), 2.65 (d, J = 23.2 Hz, 2H), 4.10 (dq, J
d = 7.2, J
q = 7.2 Hz, 8H), 6.05 (dd, J = 10.8, 5.6 Hz, 2H), 6.16-6.28 (m, 2H), 6.27 (dd, J = 15.2, 2.4 Hz, 2H), 6.46 (dd, J = 15.2, 10.8 Hz, 2H), 6.56-6.66 (m, 2H) ppm; 13C NMR δ = 12.7, 16.5 (d, J = 6.0 Hz), 18.2 (d, J = 3.0 Hz), 37.5 (d, J = 136.0 Hz), 61.9 (d, J = 6.7 Hz), 127.2 (d, J = 6.7 Hz), 128.5 (d, J = 14.2 Hz), 129.8, 130.2 (d, J = 14.1 Hz), 132.2, 136.0, 137.7 (d, J = 6.7 Hz) ppm; IR (KBr) 2995, 2915, 1734, 1679, 1456, 1385, 1251, 1166, 1023, 960, 847, 783, 733 cm-1; HRMS (FAB) calcd for C28H46O6P2 540.2770, found 540.2769.(1.46 g, 3.62 mmol, 2.9 eq.) Of structure 5 and 2,7-dimethyl-2,4,6-octatrienedi (198 mg, 1.21 mmol, 1 eq.) Is dissolved in THF (36 mL) and cooled to -78 < 0 > C. To this is added slowly 1M NaHMDS (4.0 mL, 4.0 mmol, 3.1 equiv) for 15 min. The pale yellow solution gradually turns red as NaHMDS is added. The mixture is stirred at -78 < 0 > C for 1.5 h, stirred at 0 < 0 > C for 3.5 h and then quenched with 10% ammonium chloride solution. The reaction mixture is extracted with ethyl acetate, washed with brine, dried over anhydrous potassium carbonate, filtered and the filtrate is concentrated under reduced pressure to give 1.52 g of a red liquid. This was purified by silica gel column chromatography (30% -100% acetone / hexane) to obtain tetraethyl bis (phosphonate) (422 mg, 0.78 mmol, all- E / Z = 6 : 1) was obtained in a yield of 64%. Data for [formula 2]: R f = 0.19 (50% acetone / hexane); 1 H NMR δ = 1.31 (t , J = 7.2 Hz, 12H), 1.94 (s, 6H), 1.96 (d, J = 4.4 Hz, 6H), 2.65 (d, J = 23.2 Hz, 2H), 4.10 ( dq, J d = 7.2, J q = 7.2 Hz, 8H), 6.05 (dd, J = 10.8, 5.6 Hz, 2H), 6.16-6.28 (m, 2H), 6.27 (dd, J = 15.2, 2.4 Hz, 2H), 6.46 (dd, J = 15.2, 10.8 Hz, 2H), 6.56-6.66 (m, 2H) ppm; 13 C NMR δ = 12.7, 16.5 (d, J = 6.0 Hz), 18.2 (d, J = 3.0 Hz), 37.5 (d, J = 136.0 Hz), 61.9 (d, J = 6.7 Hz), 127.2 (d J = 6.7 Hz), 128.5 (d, J = 14.2 Hz), 129.8, 130.2 (d, J = 14.1 Hz), 132.2, 136.0, 137.7 (d, J = 6.7 Hz) ppm; IR (KBr) 2995, 2915, 1734, 1679, 1456, 1385, 1251, 1166, 1023, 960, 847, 783, 733 cm -1 ; HRMS (FAB) calcd for C 28 H 46 O 6 P 2 540.2770, found 540.2769.
실시예 7. [구조식 1-1]로 표시되는 화합물 Example 7. Synthesis of Compound [1-1]
4,4'-(3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(methylbenzene).4,4 '- (3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) bis (methylbenzene).
구조식 2의 테트라에틸 비스(포스포네이트)(83 mg, 0.15 mmol)와 p-톨루알데하이드(92 mg, 0.77 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(269 mg, 3.84 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 환류 교반한 다음 실온으로 식힌다. 대부분의 용매를 감압하에 제거한 뒤, 디에틸에테르로 묽히고 이를 10% 염화암모늄 용액으로 씻는다. 수용액을 다시 CH2Cl2로 추출하고, 유기 층을 합하여 무수 탄산칼륨으로 건조하고, 필터한 뒤, 여액을 감압 하에 농축시켜 검붉은색 고체를 얻는다. 이를 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-1로 표시되는 카로틴 화합물(42 mg, 0.090 mmol, 9-(Z))을 58%의 수율로 얻을 수 있었다. Data for 9-(Z)-[구조식 1-1]: 1H NMR δ = 1.99 (s, 3H), 2.02 (s, 3H), 2.04 (s, 6H), 2.34 (s, 3H), 2.35 (s, 3H), 6.15 (d, J = 11.6 Hz, 1H), 6.24-6.34 (m, 2H), 6.32 (d, J = 11.6 Hz, 1H), 6.34 (d, J = 14.8 Hz, 1H), 6.41 (d, J = 14.8 Hz, 1H), 6.56 (d, J = 15.6 Hz, 1H), 6.60 (d, J = 15.6 Hz, 1H), 6.59-6.72 (m, 2H), 6.67 (dd, J = 14.8, 11.6 Hz, 1H), 6.86 (d, J = 16.0 Hz, 1H), 6.88 (dd, J = 14.8, 11.6 Hz, 1H), 7.08-7.20 (m, 4H), 7.30-7.40 (m, 4H), 7.39 (d, J = 16.0 Hz, 1H) ppm; 13C NMR δ = 12.8, 12.9, 12.9, 20.9, 21.2, 21.3, 123.6, 124.6, 125.0, 126.2, 126.4, 127.4, 129.1, 129.4, 129.4, 130.1, 130.2, 131.1, 132.7, 132.7, 132.9, 134.0, 135.0, 135.0, 135.6, 136.4, 136.5, 136.5, 137.0, 137.3, 137.4, 138.0 ppm; UV (CH2Cl2, c = 1.69×10-4) λ(ε) = 455 (4,740), 481 (5,640), 514 (4,560) nm; IR (KBr) 3023, 2922, 2855, 1733, 1677, 1606, 1513, 1446, 1375, 1241, 1215, 1182, 1111. 1044, 965, 839, 805, 757 cm-1; HRMS (FAB) calcd for C36H40 472.3130, found 472.3133.Tetraethyl bis (phosphonate) (83 mg, 0.15 mmol) and p -tolualdehyde (92 mg, 0.77 mmol) of the structural formula 2 were dissolved in methanol (30 mL) and toluene (30 mL) 3.84 mmol). The mixture is refluxed for 12 hours at a temperature of 110 < 0 > C under an argon atmosphere and then allowed to cool to room temperature. Most of the solvent is removed under reduced pressure, diluted with diethyl ether and washed with 10% ammonium chloride solution. The aqueous solution is extracted again with CH 2 Cl 2 , and the combined organic layers are dried over anhydrous potassium carbonate, filtered, and the filtrate is concentrated under reduced pressure to give a dark red solid. This was purified by recrystallization using methanol to obtain a carotene compound (42 mg, 0.090 mmol, 9- ( Z )) represented by the structural formula 1-1 in red solid at a yield of 58%. Data for 9- (Z) - [Structural Formula 1-1]: 1 H NMR δ = 1.99 (s, 3H), 2.02 (s, 3H), 2.04 (s, 6H), 2.34 (s, 3H), 2.35 ( s, 3H), 6.15 (d , J = 11.6 Hz, 1H), 6.24-6.34 (m, 2H), 6.32 (d, J = 11.6 Hz, 1H), 6.34 (d, J = 14.8 Hz, 1H), 6.41 (d, J = 14.8 Hz , 1H), 6.56 (d, J = 15.6 Hz, 1H), 6.60 (d, J = 15.6 Hz, 1H), 6.59-6.72 (m, 2H), 6.67 (dd, J = 14.8, 11.6 Hz, 1H) , 6.86 (d, J = 16.0 Hz, 1H), 6.88 (dd, J = 14.8, 11.6 Hz, 1H), 7.08-7.20 (m, 4H), 7.30-7.40 (m, 4H), 7.39 (d, J = 16.0 Hz, 1H) ppm; 13 C NMR? = 12.8, 12.9, 12.9, 20.9, 21.2, 21.3, 123.6, 124.6, 125.0, 126.2, 126.4, 127.4, 129.1, 129.4, 129.4, 130.1, 130.2, 131.1, 132.7, 132.7, 132.9, 134.0, , 135.0, 135.6, 136.4, 136.5, 136.5, 137.0, 137.3, 137.4, 138.0 ppm; UV (CH 2 Cl 2 , c = 1.69 × 10 -4 )? (?) = 455 (4,740), 481 (5,640), 514 (4,560) nm; IR (KBr) 3023, 2922, 2855, 1733, 1677, 1606, 1513, 1446, 1375, 1241, 1215, 1182, 1111, 1044, 965, 839, 805, 757 cm -1 ; HRMS (FAB) calcd for C 36 H 40 472.3130, found 472.3133.
실시예 8. [구조식 1-2]로 표시되는 화합물 Example 8. A compound represented by the formula [1-2]
4,4'-(3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(bromobenzene).4,4 '- (3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) bis (bromobenzene).
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트)(221 mg, 0.41 mmol)와 p-브로모벤즈알데하이드(378 mg, 2.04 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(717 mg, 10.22 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-2로 표시되는 카로틴 화합물(131 mg, 0.217 mmol, 9-(Z))을 53%의 수율로 얻을 수 있었다. Data for 9-(Z)-[구조식 1-2]: 1H NMR δ = 1.99 (s, 3H), 2.03 (s, 3H), 2.04 (s, 3H), 2.06 (s, 3H), 6.20 (d, J = 11.2 Hz, 1H), 6.26-6.34 (m, 2H), 6.35 (d, J = 11.2 Hz, 1H), 6.36 (d, J = 14.8 Hz, 1H), 6.43 (d, J = 14.8 Hz, 1H), 6.50 (d, J = 15.6 Hz, 1H), 6.53 (d, J = 15.6 Hz, 1H), 6.62-6.71 (m, 2H), 6.67 (dd, J = 14.8, 11.2 Hz, 1H), 6.86 (dd, J = 14.8, 11.2 Hz, 1H), 6.87 (d, J = 15.6 Hz, 1H), 7.29 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.8 Hz, 2H), 7.41 (d, J = 15.6 Hz, 1H), 7.43 (d, J = 8.8 Hz, 2H), 7.46 (d, J = 8.4 Hz, 2H) ppm; 13C NMR δ = 12.8, 12.8, 12.9, 20.8, 120.7, 121.1, 123.4, 124.9, 126.0, 126.1, 127.7, 127.7, 128.0, 128.0, 130.3, 130.4, 131.7, 131.7, 131.7, 131.7, 132.1, 133.1, 133.3, 133.7, 134.2, 136.5, 136.6, 136.7, 137.9, 138.6 ppm; UV (CH2Cl2, c = 8.96×10-6) λ(ε) = 452 (79,600), 478 (104,800), 510 (86,000) nm; IR (KBr) 3027, 2922, 2855, 1729, 1707, 1588, 1483, 1401, 1245, 1215, 1178, 1103, 1073, 1006, 962, 820, 753, 663, 514 cm-1; HRMS (FAB) calcd for C34H34Br2 602.1027, found 600.1032.(221 mg, 0.41 mmol) and p -bromobenzaldehyde (378 mg, 2.04 mmol) of the structural formula 2 were dissolved in methanol (30 mL) and toluene (30 mL, ) Followed by KOMe (717 mg, 10.22 mmol). The mixture was reacted at 110 ° C. for 12 hours under an argon atmosphere, and then purified by recrystallization using methanol to obtain 131 mg (0.217 mmol) of 9- ( Z )) Was obtained in a yield of 53%. Data for 9- (Z) - [Structural Formula 1-2]: 1 H NMR δ = 1.99 (s, 3H), 2.03 (s, 3H), 2.04 (s, 3H), 2.06 (s, 3H), 6.20 ( d, J = 11.2 Hz, 1H ), 6.26-6.34 (m, 2H), 6.35 (d, J = 11.2 Hz, 1H), 6.36 (d, J = 14.8 Hz, 1H), 6.43 (d, J = 14.8 Hz, 1H), 6.50 (d , J = 15.6 Hz, 1H), 6.53 (d, J = 15.6 Hz, 1H), 6.62-6.71 (m, 2H), 6.67 (dd, J = 14.8, 11.2 Hz, 1H ), 6.86 (dd, J = 14.8, 11.2 Hz, 1H), 6.87 (d, J = 15.6 Hz, 1H), 7.29 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.8 Hz, 2H ), 7.41 (d, J = 15.6 Hz, 1H), 7.43 (d, J = 8.8 Hz, 2H), 7.46 (d, J = 8.4 Hz, 2H) ppm; 13 C NMR? = 12.8, 12.8, 12.9, 20.8, 120.7, 121.1, 123.4, 124.9, 126.0, 126.1, 127.7, 127.7, 128.0, 128.0, 130.3, 130.4, 131.7, 131.7, 131.7, 131.7, 132.1, 133.1, 133.3 , 133.7, 134.2, 136.5, 136.6, 136.7, 137.9, 138.6 ppm; UV (CH 2 Cl 2 , c = 8.96 × 10 -6 )? (?) = 452 (79,600), 478 (104,800), 510 (86,000) nm; IR (KBr) 3027, 2922, 2855, 1729, 1707, 1588, 1483, 1401, 1245, 1215, 1178, 1103, 1073, 1006, 962, 820, 753, 663, 514 cm -1 ; HRMS (FAB) calcd for C 34 H 34 Br 2 602.1027, found 600.1032.
실시예 9. [구조식 1-3]으로 표시되는 화합물 Example 9. A compound represented by the formula [1-3]
5,5'-(3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(1,3-dimethylbenzene).5,5 '- (3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) bis (1,3-dimethylbenzene) .
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트)(176 mg, 0.33 mmol)와 3,5-디메틸벤즈알데하이드(218 mg, 1.63 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(570 mg, 8.13 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-3으로 표시되는 카로틴 화합물(81 mg, 0.162 mmol, all-(E))을 50%의 수율로 얻을 수 있었다. Data for all-(E)-[구조식 1-3]: 1H NMR δ = 1.99 (s, 6H), 2.03 (s, 6H), 2.31 (s, 12H), 6.26-6.32 (m, 2H), 6.33 (d, J = 12.4 Hz, 2H), 6.41 (d, J = 14.8 Hz, 2H), 6.53 (d, J = 16.0 Hz, 2H), 6.62-6.69 (m, 2H), 6.68 (dd, J = 14.8, 12.4 Hz, 2H), 6.86 (s, 2H), 6.88 (d, J = 16.0 Hz, 2H), 7.06 (s, 4H) ppm; 13C NMR δ = 12.8, 12.9, 21.3, 124.3, 124.3, 125.1, 127.7, 129.0, 130.3, 132.9, 133.0, 133.3, 135.7, 136.6, 137.7, 138.0 ppm; UV (CH2Cl2, c = 1.08×10-5) λ (ε) = 455 (65,400), 481 (86,500), 515 (72,100) nm; IR (KBr) 3027, 2922, 2855, 1737, 1595, 1558, 1461, 1439, 1394, 1372, 1245, 1029, 1006, 962, 895, 849, 775, 686 cm-1; HRMS (FAB) calcd for C38H44 500.3443, found 500.3434.Tetraethyl bis (phosphonate) (176 mg, 0.33 mmol) and 3,5-dimethylbenzaldehyde (218 mg, 1.63 mmol) in the same manner as in Example 7 were dissolved in methanol (30 mL) and toluene (30 mL) mL) and KOMe (570 mg, 8.13 mmol) is added. The mixture was reacted at 110 ° C. for 12 hours under an argon atmosphere and then purified by recrystallization using methanol to obtain a carotene compound represented by the structural formula 1-3 of red solid (81 mg, 0.162 mmol, all- ( E )) Was obtained in a yield of 50%. Data for all- (E) - [Structural Formula 1-3]: 1 H NMR δ = 1.99 (s, 6H), 2.03 (s, 6H), 2.31 (s, 12H), 6.26-6.32 (m, 2H), 6.33 (d, J = 12.4 Hz , 2H), 6.41 (d, J = 14.8 Hz, 2H), 6.53 (d, J = 16.0 Hz, 2H), 6.62-6.69 (m, 2H), 6.68 (dd, J = 14.8, 12.4 Hz, 2H), 6.86 (s, 2H), 6.88 (d, J = 16.0 Hz, 2H), 7.06 (s, 4H) ppm; 13 C NMR? = 12.8, 12.9, 21.3, 124.3, 124.3, 125.1, 127.7, 129.0, 130.3, 132.9, 133.0, 133.3, 135.7, 136.6, 137.7, 138.0 ppm; UV (CH 2 Cl 2 , c = 1.08 × 10 -5 ) λ (ε) = 455 (65,400), 481 (86,500), 515 (72,100) nm; IR (KBr) 3027, 2922, 2855, 1737, 1595, 1558, 1461, 1439, 1394, 1372, 1245, 1029, 1006, 962, 895, 849, 775, 686 cm -1 ; HRMS (FAB) calcd for C 38 H 44 500.3443, found 500.3434.
실시예 10. [구조식 1-4]로 표시되는 화합물 Example 10. A compound represented by the structural formula 1-4
6,6'-(3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(1,2,3,4-tetramethoxy-5-methylbenzene).6,6 '- (3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) bis 4-tetramethoxy-5-methylbenzene).
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트)(423 mg, 0.78 mmol)와 1,2,3,4-테트라메톡시-5-메틸벤즈알데하이드(940 mg, 3.91 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(1.37 g, 19.55 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 24시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-4로 표시되는 카로틴 화합물(134 mg, 0.187 mmol, all-(E))을 24%의 수율로 얻을 수 있었다. Data for all-(E)-[구조식 1-4]: 1H NMR δ = 2.00 (s, 6H), 2.07 (s, 6H), 2.25 (s, 6H), 3.77 (s, 6H), 3.79 (s, 6H), 3.92 (s, 6H), 3.94 (s, 6H), 6.22-6.37 (m, 2H), 6.29 (d, J = 11.2 Hz, 2H), 6.41 (d, J = 15.2 Hz, 2H), 6.56 (d, J = 16.4 Hz, 2H), 6.60-6.72 (m, 2H), 6.69 (dd, J = 15.2, 11.2 Hz, 2H), 6.86 (d, J = 16.4 Hz, 2H) ppm; 13CNMR δ = 12.6, 12.8, 13.0, 60.5, 60.7, 61.2, 61.3, 121.5, 125.0, 125.1, 126.6, 130.2, 132.8, 132.9, 136.2, 136.6, 138.1, 138.6, 144.9, 145.7, 148.0, 148.1 ppm; UV (CH2Cl2, c = 2.39×10-5) λ (ε) = 452 (36,700), 474 (37,600) nm; IR (KBr) 2989, 2937, 2855, 2833, 1729, 1677, 1565, 1469, 1409, 1349, 1267, 1193, 1111, 1081, 1066, 1036, 1014, 969, 887, 753 cm-1; HRMS (FAB) calcd for C44H56O8 712.3975, found 712.3967.Tetraethylbis (phosphonate) (423 mg, 0.78 mmol) and 1,2,3,4-tetramethoxy-5-methylbenzaldehyde (940 mg, 3.91 mmol) in a similar manner to Example 7, Is dissolved in methanol (30 mL) and toluene (30 mL), followed by KOMe (1.37 g, 19.55 mmol). The mixture was reacted at 110 ° C for 24 hours under an argon atmosphere, and then purified by recrystallization using methanol to obtain 134 mg of a carotene compound represented by Structural Formula 1-4 (134 mg, 0.187 mmol, all- ( E )) Was obtained in a yield of 24%. Data for all- (E) - [Structural Formula 1-4]: 1 H NMR δ = 2.00 (s, 6H), 2.07 (s, 6H), 2.25 (s, 6H), 3.77 (s, 6H), 3.79 ( (m, 2H), 6.29 (d, J = 11.2 Hz, 2H), 6.41 (d, J = 15.2 Hz, 2H), 3.92 (s, 6H) ), 6.56 (d, J = 16.4 Hz, 2H), 6.60-6.72 (m, 2H), 6.69 (dd, J = 15.2, 11.2 Hz, 2H), 6.86 (d, J = 16.4 Hz, 2H) ppm; 13 C NMR? = 12.6, 12.8, 13.0, 60.5, 60.7, 61.2, 61.3, 121.5, 125.0, 125.1, 126.6, 130.2, 132.8, 132.9, 136.2, 136.6, 138.1, 138.6, 144.9, 145.7, 148.0, 148.1 ppm; UV (CH 2 Cl 2 , c = 2.39 × 10 -5 )? (?) = 452 (36,700), 474 (37,600) nm; IR (KBr) 2989, 2937, 2855, 2833, 1729, 1677, 1565, 1469, 1409, 1349, 1267, 1193, 1111, 1081, 1066, 1036, 1014, 969, 887, 753 cm -1 ; HRMS (FAB) calcd for C 44 H 56 O 8 712.3975, found 712.3967.
실시예 11. [구조식 1-5]로 표시되는 화합물 Example 11 A compound represented by the structural formula 1-5
4,4'-(3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(N,N-diphenylaniline).4,4 '- (3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) bis (N, N-diphenylaniline) .
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트)(106 mg, 0.196 mmol)와 4-(디페닐아미노)벤즈알데하이드(268 mg, 0.98 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(344 mg, 4.90 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-5로 표시되는 카로틴 화합물(67 mg, 0.086 mmol, all-(E))을 44%의 수율로 얻을 수 있었다. Data for all-(E)-[구조식 1-5]: 1H NMR δ = 1.99 (s, 6H), 2.04 (s, 6H), 6.25-6.32 (m, 2H), 6.31 (d, J = 11.6 Hz, 2H), 6.40 (d, J = 15.2 Hz, 2H), 6.54 (d, J = 15.6 Hz, 2H), 6.62-6.69 (m, 2H), 6.68 (dd, J = 15.2, 11.6 Hz, 2H), 6.80 (d, J = 15.6 Hz, 2H), 7.00-7.34 (m, 28H) ppm; 13C NMR δ = 12.8, 12.9, 122.9, 123.6, 124.4, 125.1, 126.0, 127.1, 129.2, 130.2, 132.0, 132.1, 132.5, 132.9, 135.8, 136.6, 137.8, 146.9, 147.5 ppm; IR (KBr) 3034, 2922, 2855, 1737, 1588, 1491, 1327, 1282, 1178, 962, 895, 835, 753, 693 cm-1; HRMS (FAB) calcd for C58H54N2 778.4287, found 778.4297.(106 mg, 0.196 mmol) and 4- (diphenylamino) benzaldehyde (268 mg, 0.98 mmol) of the structural formula 2 were dissolved in methanol (30 mL) and toluene (30 mL), followed by KOMe (344 mg, 4.90 mmol). The mixture was reacted at 110 ° C for 12 hours under an argon atmosphere, and then purified by recrystallization using methanol to obtain a carotene compound (67 mg, 0.086 mmol, all- ( E )) Was obtained in a yield of 44%. Data for all- (E) - [Structural Formula 1-5]: 1 H NMR δ = 1.99 (s, 6H), 2.04 (s, 6H), 6.25-6.32 (m, 2H), 6.31 (d, J = 11.6 Hz, 2H), 6.40 (d , J = 15.2 Hz, 2H), 6.54 (d, J = 15.6 Hz, 2H), 6.62-6.69 (m, 2H), 6.68 (dd, J = 15.2, 11.6 Hz, 2H ), 6.80 (d, J = 15.6 Hz, 2H), 7.00-7.34 (m, 28H) ppm; 13 C NMR? = 12.8, 12.9, 122.9, 123.6, 124.4, 125.1, 126.0, 127.1, 129.2, 130.2, 132.0, 132.1, 132.5, 132.9, 135.8, 136.6, 137.8, 146.9, 147.5 ppm; IR (KBr) 3034, 2922, 2855, 1737, 1588, 1491, 1327, 1282, 1178, 962, 895, 835, 753, 693 cm -1 ; HRMS (FAB) calcd for C 58 H 54 N 2 778.4287, found 778.4297.
실시예 12. [구조식 1-6]으로 표시되는 화합물 Example 12. A compound represented by the formula [1-6]
((3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(4,1-phenylene))bis(methylsulfane).(3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) bis (4,1-phenylene)) bis (methylsulfane ).
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트)(605 mg, 1.12 mmol)와 4-(메틸티오)벤즈알데하이드(852 mg, 5.6 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(1.96 g, 27.98 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-6으로 표시되는 카로틴 화합물(251 mg, 0.468 mmol, 9-(Z))을 42%의 수율로 얻을 수 있었다. Data for 9-(Z)-[구조식 1-6]: 1H NMR δ = 1.99 (s, 3H), 2.03 (s, 3H), 2.04 (s, 6H), 2.49 (s, 3H), 2.50 (s, 3H), 6.16 (d, J = 11.6 Hz, 1H), 6.26-6.36 (m, 2H), 6.33 (d, J = 11.6 Hz, 1H), 6.35 (d, J = 14.8 Hz, 1H), 6.42 (d, J = 14.8, 1H), 6.53 (d, J = 14.8 Hz, 1H), 6.57 (d, J = 14.8 Hz, 1H), 6.60-6.70 (m, 2H), 6.67 (dd, J = 14.8, 11.6 Hz, 1H, calcd), 6.86 (d, J = 14.8 Hz, 1H), 6.88 (dd, J = 14.8, 11.6 Hz, 1H, calcd), 7.20 (d, J = 8.0 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 14.8 Hz, 1H, calcd), 7.40 (d, J = 8.0 Hz, 2H) ppm; 13C NMR δ = 12.8, 12.9, 12.9, 15.8, 15.8, 20.8, 123.5, 124.9, 125.0, 126.6, 126.6, 126.7, 126.7, 126.8, 126.8, 126.8, 126.8, 126.9, 128.5, 130.2, 130.2, 130.3, 131.4, 132.9, 133.0, 133.1, 133.8, 134.7, 134.8, 135.5, 136.5, 136.5, 137.2, 137.5, 137.6, 138.2 ppm; IR (KBr) 2975, 2932, 1750, 1442, 1383, 1231, 1064, 972, 902, 778 cm-1; UV (CH2Cl2, c = 8.67×10-6) λ (ε) = 462 (53,000), 485 (60,000), 517 (45,000) nm; HRMS (FAB) calcd for C36H40S2 536.2571, found 536.2581. (605 mg, 1.12 mmol) and 4- (methylthio) benzaldehyde (852 mg, 5.6 mmol) of the structural formula 2 were dissolved in methanol (30 mL) and toluene 30 mL), followed by KOMe (1.96 g, 27.98 mmol). The mixture was reacted at 110 ° C for 12 hours under an argon atmosphere and then purified by recrystallization using methanol to obtain 251 mg of a carotene compound represented by Structural Formula 1-6 (0.468 mmol, 9- ( Z )) Was obtained in a yield of 42%. Data for 9- (Z) - [Structural Formula 1-6]: 1 H NMR δ = 1.99 (s, 3H), 2.03 (s, 3H), 2.04 (s, 6H), 2.49 (s, 3H), 2.50 ( s, 3H), 6.16 (d , J = 11.6 Hz, 1H), 6.26-6.36 (m, 2H), 6.33 (d, J = 11.6 Hz, 1H), 6.35 (d, J = 14.8 Hz, 1H), 6.42 (d, J = 14.8, 1H), 6.53 (d, J = 14.8 Hz, 1H), 6.57 (d, J = 14.8 Hz, 1H), 6.60-6.70 (m, 2H), 6.67 (dd, J = 14.8, 11.6 Hz, 1H, calcd ), 6.86 (d, J = 14.8 Hz, 1H), 6.88 (dd, J = 14.8, 11.6 Hz, 1H, calcd), 7.20 (d, J = 8.0 Hz, 2H), 7.25 (d, J = 8.0 Hz , 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 14.8 Hz, 1H, calcd), 7.40 (d, J = 8.0 Hz, 2H) ppm ; 13 C NMR? = 12.8, 12.9, 12.9, 15.8, 15.8, 20.8, 123.5, 124.9, 125.0, 126.6, 126.6, 126.7, 126.7, 126.8, 126.8, 126.8, 126.8, 126.9, 128.5, 130.2, 130.2, 130.3, 131.4 , 132.9, 133.0, 133.1, 133.8, 134.7, 134.8, 135.5, 136.5, 136.5, 137.2, 137.5, 137.6, 138.2 ppm; IR (KBr) 2975, 2932, 1750, 1442, 1383, 1231, 1064, 972, 902, 778 cm -1 ; UV (CH 2 Cl 2 , c = 8.67 × 10 -6 )? (?) = 462 (53,000), 485 (60,000), 517 (45,000) nm; HRMS (FAB) calcd for C 36 H 40 S 2 536.2571, found 536.2581.
실시예 13. [구조식 1-7]로 표시되는 화합물 Example 13 A compound represented by the structural formula 1-7
((3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(3,5-dimethyl-4,1-phenylene))bis(methylsulfane).((3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) bis (3,5-dimethyl- phenylene)) bis (methylsulfane).
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트)(800 mg, 1.48 mmol)와 2,6-디메틸-4-(메틸티오)벤즈알데하이드(934 mg, 5.18 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(2.07 g, 29.60 mmol)를 더한다. 상기 혼합물을 아르곤 대기 하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-7로 표시되는 카로틴 화합물(196 mg, 0.488 mmol, all-(E))을 33%의 수율로 얻을 수 있었다. Data for all-(E)-[구조식 1-7]: 1H-NMR δ = 1.99 (s, 6H), 2.07 (s,6H), 2.31 (s,12H), 2.47 (s, 6H), 6.23 (d,J = 11.6 Hz, 2H), 6.23-6.33 (m, 2H), 6.37 (d, J = 16.4 Hz, 2H), 6.40 (d, J = 14.8 Hz, 2H), 6.54 (d, J = 16.4 Hz, 2H), 6.60-6.70 (m, 2H), 6.68 (dd, J = 14.8, 11.6 Hz, 2H), 6.96 (s, 4H) ppm; 13C-NMR δ = 12.4, 12.5, 15.6, 20.9, 20.9, 124.5, 124.8, 125.8, 129.9, 132.1, 132.6, 134.1, 135.2, 135.5, 136.3, 136.4, 137.8, 138.5 ppm; UV (CH2Cl2, c = 3.35×10-5) λ (ε) = 472 (128,000) nm; IR (KBr) 3032, 2932, 1744, 1666, 1589, 1551, 1451, 1366, 1219, 964, 772 cm-1; HRMS (FAB) calcd for C40H48S2 592.3197, found 592.3196.(800 mg, 1.48 mmol) and 2,6-dimethyl-4- (methylthio) benzaldehyde (934 mg, 5.18 mmol) of the structural formula 2 were dissolved in methanol 30 mL) and toluene (30 mL), followed by KOMe (2.07 g, 29.60 mmol). The mixture was reacted at 110 ° C for 12 hours under an argon atmosphere, and then purified by recrystallization using methanol to obtain a carotene compound (196 mg, 0.488 mmol, all- ( E )) Was obtained in a yield of 33%. Data for all- (E) - [Structural Formula 1-7]: 1 H-NMR δ = 1.99 (s, 6H), 2.07 (s, 6H), 2.31 (s, 12H), 2.47 (s, 6H), 6.23 (d, J = 11.6 Hz, 2H), 6.23-6.33 (m, 2H), 6.37 (d, J = 16.4 Hz, 2H), 6.40 (d, J = 14.8 Hz, 2H), 6.54 (d, J = 16.4 Hz, 2H), 6.60-6.70 (m, 2H), 6.68 (dd, J = 14.8, 11.6 Hz, 2H), 6.96 (s, 4H) ppm; 13 C-NMR? = 12.4, 12.5, 15.6, 20.9, 20.9, 124.5, 124.8, 125.8, 129.9, 132.1, 132.6, 134.1, 135.2, 135.5, 136.3, 136.4, 137.8, 138.5 ppm; UV (CH 2 Cl 2 , c = 3.35 × 10 -5 )? (?) = 472 (128,000) nm; IR (KBr) 3032, 2932, 1744, 1666, 1589, 1551, 1451, 1366, 1219, 964, 772 cm -1 ; HRMS (FAB) calcd for C 40 H 48 S 2 592.3197, found 592.3196.
실시예 14. [구조식 1-8]로 표시되는 화합물 Example 14. A compound represented by the structural formula 1-8
4,4'-(3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)dibenzonitrile.4,4 '- (3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) dibenzonitrile.
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트) (150 mg, 0.28 mmol)와 4-포르밀벤조나이트릴 (182 mg, 1.39 mmol)을 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe (486 mg, 6.94 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-8로 표시되는 카로틴 화합물 (42 mg, 0.084 mmol, all-(E))을 30%의 수율로 얻을 수 있었다. Data for all-(E)-[구조식 1-8]: 1H NMR δ = 2.05 (s, 6H), 2.12 (s, 6H), 6.28-6.340 (m, 2H), 6.42 (d, J = 11.6 Hz, 2H), 6.47 (d, J = 15.2 Hz, 2H), 6.55 (d, J = 15.6 Hz, 2H), 6.64-6.72 (m, 2H), 6.68 (dd, J = 15.2, 11.6 Hz, 2H), 6.99 (d, J = 15.6 Hz, 2H), 7.46-7.54 (m, 4H), 7.54-7.64 (m, 4H) ppm.(150 mg, 0.28 mmol) and 4-formylbenzonitrile (182 mg, 1.39 mmol) of the structural formula 2 were dissolved in methanol (30 mL) and toluene (30 mL) mL) and KOMe (486 mg, 6.94 mmol) is added. The mixture was reacted at 110 ° C for 12 hours under an argon atmosphere, and then purified by recrystallization using methanol to obtain a carotene compound (42 mg, 0.084 mmol, all- ( E )) Was obtained in a yield of 30%. Data for all- (E) - [Structural Formula 1-8]: 1 H NMR δ = 2.05 (s, 6H), 2.12 (s, 6H), 6.28-6.340 (m, 2H), 6.42 (d, J = 11.6 Hz, 2H), 6.47 (d , J = 15.2 Hz, 2H), 6.55 (d, J = 15.6 Hz, 2H), 6.64-6.72 (m, 2H), 6.68 (dd, J = 15.2, 11.6 Hz, 2H ), 6.99 (d, J = 15.6 Hz, 2H), 7.46-7.54 (m, 4H), 7.54-7.64 (m, 4H) ppm.
실시예 15. [구조식 1-9]로 표시되는 화합물 Example 15. A compound represented by the structural formula 1-9
2,2'-(3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(methylbenzene).2,2 '- (3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) bis (methylbenzene).
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트) (154 mg, 0.28 mmol)와 o-톨루알데하이드 (171 mg, 1.42 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe (499 mg, 7.12 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-9로 표시되는 카로틴 화합물(57 mg, 0.12 mmol, all-(E))을 43%의 수율로 얻을 수 있었다. Data for all-(E)-[구조식 1-9]: 1H NMR δ = 2.00 (s, 6H), 2.07 (s, 6H), 2.39 (s, 6H), 6.25-6.35 (m, 2H), 6.34 (d, J = 11.6 Hz, 2H), 6.42 (d, J = 14.8 Hz, 2H), 6.62-6.71 (m, 2H), 6.69 (dd, J = 14.8, 11.6 Hz, 2H), 6.78 (d, J = 16.0 Hz, 2H), 6.82 (d, J = 16.0 Hz, 2H), 7.10-7.21 (m, 6H), 7.53 (d, J = 8.0 Hz, 4H) ppm; 13C NMR δ = 12.8, 13.0, 19.9, 124.9, 124.9, 125.0, 126.1, 127.1, 130.3, 130.4, 133.1, 133.1, 134.8, 135.5, 135.8, 136.6, 136.6, 138.2 ppm.(154 mg, 0.28 mmol) and o -tolualdehyde (171 mg, 1.42 mmol) in the same manner as in Example 7 were dissolved in methanol (30 mL) and toluene (30 mL) After dissolving, add KOMe (499 mg, 7.12 mmol). The mixture was reacted at 110 ° C for 12 hours under an argon atmosphere and purified by recrystallization using methanol to obtain a carotene compound (57 mg, 0.12 mmol, all- ( E )) Was obtained in a yield of 43%. Data for all- (E) - [Structural Formula 1-9]: 1 H NMR δ = 2.00 (s, 6H), 2.07 (s, 6H), 2.39 (s, 6H), 6.25-6.35 (m, 2H), 6.34 (d, J = 11.6 Hz , 2H), 6.42 (d, J = 14.8 Hz, 2H), 6.62-6.71 (m, 2H), 6.69 (dd, J = 14.8, 11.6 Hz, 2H), 6.78 (d J = 16.0 Hz, 2H), 6.82 (d, J = 16.0 Hz, 2H), 7.10-7.21 (m, 6H), 7.53 (d, J = 8.0 Hz, 4H) ppm; 13 C NMR? = 12.8, 13.0, 19.9, 124.9, 124.9, 125.0, 126.1, 127.1, 130.3, 130.4, 133.1, 133.1, 134.8, 135.5, 135.8, 136.6, 136.6, 138.2 ppm.
실시예 16. [구조식 1-10]으로 표시되는 화합물 Example 16. A compound represented by the formula [1-10]
4,4'-(3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(methoxybenzene).4,4 '- (3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) bis (methoxybenzene).
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트) (143 mg, 0.27 mmol)와 p-아니실알데하이드 (180 mg, 1.32 mmol)를 메탄올 (30 mL)과 톨루엔 (30 mL)에 녹인 다음 KOMe (464 mg, 6.61 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 24시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-10으로 표시되는 카로틴 화합물 (39 mg, 0.77 mmol, 9-(Z))을 29%의 수율로 얻을 수 있었다. Data for 9-(Z)-[구조식 1-10]: 1H NMR δ = 1.99 (s, 3H), 2.02 (s, 3H), 2.04 (s, 6H), 3.83 (s, 6H), 6.13 (d, J = 10.4 Hz, 1H), 6.22-6.35 (m, 2H), 6.31 (d, J = 11.2 Hz, 1H), 6.34 (d, J = 14.0 Hz, 1H), 6.40 (d, J = 14.8, 1H), 6.54 (d, J = 15.2 Hz, 1H), 6.58 (d, J = 16.0 Hz, 1H), 6.59-6.73 (m, 2H), 6.67 (dd, J = 14.8, 11.2 Hz, 1H, calcd), 6.78 (d, J = 15.2 Hz, 1H), 6.87 (d, J = 8.0 Hz, 2H), 6.89 (d, J = 8.0 Hz, 2H), 6.92 (dd, J = 14.0, 10.4 Hz, 1H, cacld), 7.32 (d, J = 16.0 Hz, 1H), 7.37 (d, J = 8.0 Hz, 2H), 7.43 (d, J = 8.0 Hz, 2H) ppm.(300 mg, 0.27 mmol) and p -anisylaldehyde (180 mg, 1.32 mmol) in the same manner as in Example 7 were dissolved in methanol (30 mL) and toluene (30 mL) Followed by KOMe (464 mg, 6.61 mmol). The mixture was reacted at 110 ° C for 24 hours under an argon atmosphere, and then purified by recrystallization using methanol to obtain a carotene compound (39 mg, 0.77 mmol, 9- ( Z )) Was obtained in a yield of 29%. Data for 9- (Z) - [Structural Formula 1-10]: 1 H NMR δ = 1.99 (s, 3H), 2.02 (s, 3H), 2.04 (s, 6H), 3.83 (s, 6H), 6.13 ( d, J = 10.4 Hz, 1H ), 6.22-6.35 (m, 2H), 6.31 (d, J = 11.2 Hz, 1H), 6.34 (d, J = 14.0 Hz, 1H), 6.40 (d, J = 14.8 , 1H), 6.54 (d, J = 15.2 Hz, 1H), 6.58 (d, J = 16.0 Hz, 1H), 6.59-6.73 (m, 2H), 6.67 (dd, J = 14.8, 11.2 Hz, 1H, calcd), 6.78 (d, J = 15.2 Hz, 1H), 6.87 (d, J = 8.0 Hz, 2H), 6.89 (d, J = 8.0 Hz, 2H), 6.92 (dd, J = 14.0, 10.4 Hz, 1H, cacld), 7.32 (d , J = 16.0 Hz, 1H), 7.37 (d, J = 8.0 Hz, 2H), 7.43 (d, J = 8.0 Hz, 2H) ppm.
실시예 17. [구조식 1-11]로 표시되는 화합물 Example 17 A compound represented by the structural formula 1-11
3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)dibenzene.3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) dibenzene.
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트)(155 mg, 0.287 mmol)와 벤즈알데하이드(152 mg, 1.43 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(503 g, 7.18 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-11로 표시되는 카로틴 화합물 (68 mg, 0.152 mmol)을 53%의 수율로 얻을 수 있었다. 상기 반응물의 정제에서 디에틸에테르로 추출한 용액으로부터 얻은 고체를 메탄올로 재결정하여 9-(Z)-카로틴을 얻을 수 있고, 디에틸에테르에 잘 녹지 않고 수용액층에 부유하였던 소량의 물질을 CH2Cl2로 추출하여 얻은 고체를 메탄올로 재결정하여 all-(E)-카로틴을 얻을 수 있었다.Tetraethyl bis (phosphonate) (155 mg, 0.287 mmol) and benzaldehyde (152 mg, 1.43 mmol) in the same manner as in Example 7 were dissolved in methanol (30 mL) and toluene (30 mL) Add KOMe (503 g, 7.18 mmol). The mixture was reacted at 110 DEG C for 12 hours under an argon atmosphere, and then purified by recrystallization using methanol to obtain a carotene compound (68 mg, 0.152 mmol) represented by the structural formula 1-11 as red solid in 53% Yield. ≪ / RTI > The solid obtained from the solution extracted with diethyl ether in the purification of the reaction product was recrystallized from methanol to obtain 9- ( Z ) -carotene. A small amount of substance which was not dissolved in diethyl ether but suspended in the aqueous solution layer was dissolved in CH 2 Cl 2, and the resulting solid was recrystallized from methanol to obtain all- ( E ) -carotene.
Data for 9-(Z)-[구조식 1-11]: 1H NMR δ = 2.00 (s, 3H), 2.03 (s, 3H), 2.05 (s, 6H), 6.18 (d, J = 11.2 Hz, 1H), 6.26-6.34 (m, 2H), 6.35 (d, J = 11.2 Hz, 1H), 6.35 (d, J = 14.8 Hz, 1H), 6.42 (d, J = 14.8 Hz, 1H), 6.58 (d, J = 15.6 Hz, 1H), 6.62 (d, J = 15.6 Hz, 1H), 6.62-6.70 (m, 2H), 6.68 (dd, J = 14.8, 11.2 Hz, 1H), 6.89 (dd, J = 14.8, 11.2 Hz, 1H; H11), 6.90 (d, J = 15.6 Hz, 1H), 7.17-7.26 (m, 2H), 7.29-7.37 (m, 4H), 7.41-7.50 (m, 4H), 7.44 (d, J = 15.6 Hz, 1H; H8) ppm; 13C NMR δ = 12.8, 12.9, 12.9, 20.9, 123.6, 125.0, 125.5, 126.3, 126.5, 127.1, 127.4, 127.5, 128.6, 128.7, 129.1, 130.2, 130.3, 131.6, 132.9, 133.1, 133.2, 133.6, 133.9, 135.5, 136.5, 136.5, 136.6, 137.5, 137.8, 138.3 ppm; UV (CH2Cl2, c = 8.43×10-4) λ (ε) = 451 (84,400), 476 (110,900), 508 (92,800) nm; IR (KBr) 3027, 2922, 2855, 1729, 1595, 1491, 1446, 1394, 1372, 1215, 1029, 962, 753, 693 cm-1; HRMS (FAB) calcd for C34H36 444.2817, found 444.2814.Data for 9- (Z) - [Structural Formula 1-11]: 1 H NMR δ = 2.00 (s, 3H), 2.03 (s, 3H), 2.05 (s, 6H), 6.18 (d, J = 11.2 Hz, 1H), 6.26-6.34 (m, 2H ), 6.35 (d, J = 11.2 Hz, 1H), 6.35 (d, J = 14.8 Hz, 1H), 6.42 (d, J = 14.8 Hz, 1H), 6.58 ( d, J = 15.6 Hz, 1H ), 6.62 (d, J = 15.6 Hz, 1H), 6.62-6.70 (m, 2H), 6.68 (dd, J = 14.8, 11.2 Hz, 1H), 6.89 (dd, J = 14.8, 11.2 Hz, 1H; H 11), 6.90 (d, J = 15.6 Hz, 1H), 7.17-7.26 (m, 2H), 7.29-7.37 (m, 4H), 7.41-7.50 (m, 4H) , 7.44 (d, J = 15.6 Hz, 1H; H 8) ppm; 13 C NMR? = 12.8, 12.9, 12.9, 20.9, 123.6, 125.0, 125.5, 126.3, 126.5, 127.1, 127.4, 127.5, 128.6, 128.7, 129.1, 130.2, 130.3, 131.6, 132.9, 133.1, 133.2, 133.6, 133.9 , 135.5, 136.5, 136.5, 136.6, 137.5, 137.8, 138.3 ppm; UV (CH 2 Cl 2 , c = 8.43 × 10 -4 )? (?) = 451 (84,400), 476 (110,900), 508 (92,800) nm; IR (KBr) 3027, 2922, 2855, 1729, 1595, 1491, 1446, 1394, 1372, 1215, 1029, 962, 753, 693 cm -1 ; HRMS (FAB) calcd for C 34 H 36 444.2817, found 444.2814.
Data for all-(E)-[구조식 1-11]: 1H NMR δ = 2.00 (s, 6H), 2.05 (s, 6H), 6.25-6.36 (m, 2H), 6.35 (d, J = 11.6 Hz, 2H), 6.43 (d, J = 14.8 Hz, 2H), 6.59 (d, J = 16.0 Hz, 2H), 6.61-6.72 (m, 2H), 6.68 (dd, J = 14.8, 11.6 Hz, 2H), 6.91 (d, J = 16.0 Hz, 2H), 7.17-67.24 (m, 2H), 7.28-7.36 (m, 4H), 7.40-7.47 (m, 4H) ppm; 13C NMR δ = 12.8, 12.9, 125.0, 126.3, 127.2, 127.4, 128.6, 130.3, 133.1, 133.2, 133.6, 135.5, 136.6, 137.8, 138.2 ppm; UV (CH2Cl2, c = 1.12×10-5) λ (ε) = 454 (57,800), 480 (81,900), 513 (72,900) nm; IR (KBr) 3027, 2945, 2915, 1722, 1662, 1595, 1573, 1551, 1491, 1446, 1334, 962, 745, 686 cm-1; HRMS (FAB) calcd for C34H36 444.2817, found 444.2816.Data for all- (E) - [Structural Formula 1-11]: 1 H NMR δ = 2.00 (s, 6H), 2.05 (s, 6H), 6.25-6.36 (m, 2H), 6.35 (d, J = 11.6 Hz, 2H), 6.43 (d , J = 14.8 Hz, 2H), 6.59 (d, J = 16.0 Hz, 2H), 6.61-6.72 (m, 2H), 6.68 (dd, J = 14.8, 11.6 Hz, 2H ), 6.91 (d, J = 16.0 Hz, 2H), 7.17-67.24 (m, 2H), 7.28-7.36 (m, 4H), 7.40-7.47 (m, 4H) ppm; 13 C NMR? = 12.8, 12.9, 125.0, 126.3, 127.2, 127.4, 128.6, 130.3, 133.1, 133.2, 133.6, 135.5, 136.6, 137.8, 138.2 ppm; UV (CH 2 Cl 2 , c = 1.12 × 10 -5 )? (?) = 454 (57,800), 480 (81,900), 513 (72,900) nm; IR (KBr) 3027, 2945, 2915, 1722, 1662, 1595, 1573, 1551, 1491, 1446, 1334, 962, 745, 686 cm -1 ; HRMS (FAB) calcd for C 34 H 36 444.2817, found 444.2816.
실시예 18. [구조식 1-12]로 표시되는 화합물 Example 18 A compound represented by the formula [1-12]
2,2'-(3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)dinaphthalene.2,2 '- (3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) dinaphthalene.
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트)(653 mg, 1.21 mmol)와 2-나프탈알데하이드(943 mg, 6.04 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(2.12 g, 30.2 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-12로 표시되는 카로틴 화합물(258 mg, 0.474 mmol, 9-(Z))을 39%의 수율로 얻을 수 있었다. Data for 9-(Z)-[구조식 1-12]: 1H-NMR δ = 2.01 (s, 3H), 2.06 (s, 3H), 2.10 (s, 3H), 2.11 (s, 3H), 6.21 (d, J = 10.8 Hz, 1H), 6.28-6.35 (m, 2H), 6.38 (d, J = 14.4 Hz, 1H), 6.40 (d, J = 11.6 Hz, 1H), 6.45 (d, J = 14.8, 1H), 6.63-6.74 (m, 2H), 6.68 (dd, J = 14.4, 10.8 Hz, 1H, calcd), 6.76 (d, J = 15.6 Hz, 1H), 6.79 (d, J = 15.6 Hz, 1H), 6.95 (dd, J = 14.8, 11.6 Hz, 1H), 7.04 (d, J = 15.6 Hz, 1H), 7.39-7.49 (m, 4H), 7.57 (d, J = 15.6 Hz, 1H), 7.64-7.84 (m, 10H) ppm; 13C NMR δ = 12.8, 12.9, 13.0, 20.9, 123.6, 123.6, 125.0, 125.7, 125.8, 126.2, 126.3, 126.3, 126.6, 127.5, 127.7, 127.7, 127.9, 128.0, 128.2, 128.3, 129.2, 129.3, 130.2, 130.4, 131.8, 132.6, 133.0, 133.0, 133.4, 133.6, 133.8, 133.8, 133.9, 134.0, 135.3, 135.4, 135.6, 136.6, 136.6, 137.7, 137.7, 138.4 ppm; IR (KBr) 3053, 3023, 2922, 2855, 1737, 1625, 1595, 1439, 1368, 1241, 1129, 1047, 1025, 962, 895, 861, 816, 745, 619 cm-1; UV (CH2Cl2, c = 7.02×10-5) λ (ε) = 458 (14,100), 484 (13,800), 517 (10,100) nm; HRMS (FAB) calcd for C42H40 544.3130, found 544.3132.(653 mg, 1.21 mmol) and 2-naphthalaldehyde (943 mg, 6.04 mmol) in the same manner as in Example 7 were dissolved in methanol (30 mL) and toluene (30 mL) Followed by KOMe (2.12 g, 30.2 mmol). The mixture was reacted at 110 ° C for 12 hours under an argon atmosphere, and then purified by recrystallization using methanol to obtain a carotene compound represented by the structural formula 1-12 (258 mg, 0.474 mmol, 9- ( Z )) Was obtained in a yield of 39%. Data for 9- (Z) - [Structural Formula 1-12]: 1 H-NMR δ = 2.01 (s, 3H), 2.06 (s, 3H), 2.10 (s, 3H), 2.11 (s, 3H), 6.21 (d, J = 10.8 Hz, 1H), 6.28-6.35 (m, 2H), 6.38 (d, J = 14.4 Hz, 1H), 6.40 (d, J = 11.6 Hz, 1H), 6.45 (d, J = 14.8, 1H), 6.63-6.74 (m , 2H), 6.68 (dd, J = 14.4, 10.8 Hz, 1H, calcd), 6.76 (d, J = 15.6 Hz, 1H), 6.79 (d, J = 15.6 Hz , 1H), 6.95 (dd, J = 14.8, 11.6 Hz, 1H), 7.04 (d, J = 15.6 Hz, 1H), 7.39-7.49 (m, 4H), 7.57 (d, J = 15.6 Hz, 1H) , 7.64-7.84 (m, 10H) ppm; 13 C NMR? = 12.8, 12.9, 13.0, 20.9, 123.6, 123.6, 125.0, 125.7, 125.8, 126.2, 126.3, 126.3, 126.6, 127.5, 127.7, 127.7, 127.9, 128.0, 128.2, 128.3, 129.2, , 130.4, 131.8, 132.6, 133.0, 133.0, 133.4, 133.6, 133.8, 133.8, 133.9, 134.0, 135.3, 135.4, 135.6, 136.6, 136.6, 137.7, 137.7, 138.4 ppm; IR (KBr) 3053, 3023, 2922, 2855, 1737, 1625, 1595, 1439, 1368, 1241, 1129, 1047, 1025, 962, 895, 861, 816, 745, 619 cm -1 ; UV (CH 2 Cl 2 , c = 7.02 10 -5 )? (?) = 458 (14,100), 484 (13,800), 517 (10,100) nm; HRMS (FAB) calcd for C 42 H 40 544.3130, found 544.3132.
실시예 19. [구조식 1-13]으로 표시되는 화합물 Example 19. A compound represented by the formula [1-13]
2,2'-(3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)difuran.2,2 '- (3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) difuran.
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트)(480 mg, 0.89 mmol)와 2-퓨랄데하이드(427 mg, 4.44 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(1.56 g, 22.2 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-13으로 표시되는 카로틴 화합물(152 mg, 0.358 mmol, all-(E))을 40%의 수율로 얻을 수 있었다. Data for all-(E)-[구조식 1-13]: 1H NMR δ = 1.99 (s, 12H), 6.25-6.35 (m, 2H), 6.27 (d, J = 3.2 Hz, 2H), 6.33 (d, J = 11.6 Hz, 2H), 6.38 (d, J = 14.8 Hz, 2H), 6.40 (dd, J = 3.2, 1.6 Hz, 2H), 6.41 (d, J = 16.0 Hz, 2H), 6.61-6.70 (m, 2H), 6.66 (dd, J = 14.8, 11.6 Hz, 2H), 6.82 (d, J = 16.0 Hz, 2H), 7.36 (d, J = 1.6 Hz, 2H) ppm; 13C NMR δ = 12.6, 12.8, 108.0, 111.7, 115.3, 125.0, 130.3, 132.2, 133.1, 133.2, 135.1, 136.6, 138.2, 141.9, 153.9 ppm; UV (CH2Cl2, c = 1.17×10-5) λ (ε) = 460 (65,400), 487 (88,400), 522 (75,000) nm; IR (KBr) 3146, 3116, 3027, 2982, 2919, 2855, 1733, 1718, 1703, 1674, 1655, 1603, 1551, 1480, 1439, 1390, 1379, 1252, 1219, 1152, 1073, 1014, 962, 928, 883, 753, 734 cm-1; HRMS (FAB) calcd for C30H32O2 424.2402, found 424.2405.(480 mg, 0.89 mmol) and 2-furaldehyde (427 mg, 4.44 mmol) in the same manner as in Example 7 were dissolved in methanol (30 mL) and toluene (30 mL) Followed by KOMe (1.56 g, 22.2 mmol). The mixture was reacted at 110 ° C for 12 hours under an argon atmosphere, and then purified by recrystallization using methanol to obtain a carotene compound (152 mg, 0.358 mmol, all- ( E )) Was obtained in a yield of 40%. Data for all- (E) - [Structural Formula 1-13]: 1 H NMR δ = 1.99 (s, 12H), 6.25-6.35 (m, 2H), 6.27 (d, J = 3.2 Hz, 2H), 6.33 ( d, J = 11.6 Hz, 2H ), 6.38 (d, J = 14.8 Hz, 2H), 6.40 (dd, J = 3.2, 1.6 Hz, 2H), 6.41 (d, J = 16.0 Hz, 2H), 6.61- 6.70 (m, 2H), 6.66 (dd, J = 14.8,11.6 Hz, 2H), 6.82 (d, J = 16.0 Hz, 2H), 7.36 (d, J = 1.6 Hz, 2H) ppm; 13 C NMR? = 12.6, 12.8, 108.0, 111.7, 115.3, 125.0, 130.3, 132.2, 133.1, 133.2, 135.1, 136.6, 138.2, 141.9, 153.9 ppm; UV (CH 2 Cl 2 , c = 1.17 x 10 -5 )? (?) = 460 (65,400), 487 (88,400), 522 (75,000) nm; IR (KBr) 3146, 3116, 3027, 2982, 2919, 2855, 1733, 1718, 1703, 1674, 1655, 1603, 1551, 1480, 1439, 1390, 1379, 1252, 1219, 1152, 1073, 928, 883, 753, 734 cm < -1 & gt ;; HRMS (FAB) calcd for C 30 H 32 O 2 424.2402, found 424.2405.
실시예 20. [구조식 1-14]로 표시되는 화합물 Example 20. A compound represented by the formula [1-14]
2,2'-(3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)dithiophene.2,2 '- (3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl) dithiophene.
실시예 7과 유사한 방법으로 구조식 2의 테트라에틸 비스(포스포네이트)(92 mg, 0.17 mmol)와 2-티오펜카르복살데하이드(95 mg, 0.85 mmol)를 메탄올(30 mL)과 톨루엔(30 mL)에 녹인 다음 KOMe(297 mg, 4.23 mmol)를 더한다. 상기 혼합물을 아르곤 대기하에서 110 ℃의 온도로 12시간 동안 반응시킨 다음 메탄올을 이용한 재결정의 방법으로 정제하여 붉은 색 고체의 구조식 1-14로 표시되는 카로틴 화합물(51 mg, 0.11 mmol, 9-(Z))을 66%의 수율로 얻을 수 있었다. Data for 9-(Z)-[구조식 1-14]: 1H NMR δ = 1.99 (s, 3H), 2.01 (s, 3H), 2.02 (s, 6H), 6.14 (d, J = 11.6 Hz, 1H), 6.26-6.34 (m, 2H), 6.31 (d, J = 11.6 Hz, 1H), 6.34 (d, J = 14.8 Hz, 1H), 6.41 (d, J = 14.8 Hz, 1H), 6.60-6.70 (m, 2H), 6.64 (d, J = 15.6 Hz, 1H), 6.66 (dd, J = 14.8, 11.6 Hz, 1H, calcd), 6.70 (d, J = 16.0 Hz, 1H), 6.74 (d, J = 16.0 Hz, 1H), 6.84 (dd, J = 14.8, 11.6 Hz, 1H), 6.96-7.01 (m, 3H), 7.03 (d, J = 3.2 Hz, 1H), 7.14 (d, J = 4.8 Hz, 1H), 7.18 (d, J = 5.2 Hz, 1H), 7.24 (d, J = 15.6 Hz, 1H) ppm; 13C-NMR δ = 12.7, 12.8, 12.9, 20.7, 120.5, 122.1, 122.5, 123.6, 123.9, 124.3, 124.9, 125.4, 125.9, 127.6, 127.7, 130.2, 130.3, 131.4, 132.9, 133.0, 133.1, 133.4, 133.5, 135.0, 136.5, 136.5, 137.5, 138.3, 143.5, 143.7 ppm; IR (KBr) 2922, 2855, 1737, 1461, 1372, 1245, 1163, 1021, 962, 850, 835, 805, 753, 693 cm-1; UV (CH2Cl2, c = 8.45×10-5) λ (ε) = 464 (8,380), 489 (11,000), 522 (9,050) nm; HRMS (FAB) calcd for C30H32S2 456.1945, found 456.1945.(92 mg, 0.17 mmol) and 2-thiophenecarboxaldehyde (95 mg, 0.85 mmol) of the structural formula 2 were dissolved in methanol (30 mL) and toluene 30 mL) and KOMe (297 mg, 4.23 mmol) was added. The mixture was reacted at 110 DEG C for 12 hours under an argon atmosphere and purified by recrystallization using methanol to obtain a carotene compound represented by the structural formula 1-14 (51 mg, 0.11 mmol, 9- ( Z )) Was obtained in a yield of 66%. Data for 9- (Z) - [Structural Formula 1-14]: 1 H NMR δ = 1.99 (s, 3H), 2.01 (s, 3H), 2.02 (s, 6H), 6.14 (d, J = 11.6 Hz, 1H), 6.26-6.34 (m, 2H ), 6.31 (d, J = 11.6 Hz, 1H), 6.34 (d, J = 14.8 Hz, 1H), 6.41 (d, J = 14.8 Hz, 1H), 6.60- 6.70 (m, 2H), 6.64 (d, J = 15.6 Hz, 1H), 6.66 (dd, J = 14.8, 11.6 Hz, 1H, calcd), 6.70 (d, J = 16.0 Hz, 1H), 6.74 (d , J = 16.0 Hz, 1H) , 6.84 (dd, J = 14.8, 11.6 Hz, 1H), 6.96-7.01 (m, 3H), 7.03 (d, J = 3.2 Hz, 1H), 7.14 (d, J = 4.8 Hz, 1H), 7.18 (d, J = 5.2 Hz, 1H), 7.24 (d, J = 15.6 Hz, 1H) ppm; 13 C-NMR? = 12.7, 12.8, 12.9, 20.7, 120.5, 122.1, 122.5, 123.6, 123.9, 124.3, 124.9, 125.4, 125.9, 127.6, 127.7, 130.2, 130.3, 131.4, 132.9, 133.0, 133.1, 133.4, 133.5, 135.0, 136.5, 136.5, 137.5, 138.3, 143.5, 143.7 ppm; IR (KBr) 2922, 2855, 1737, 1461, 1372, 1245, 1163, 1021, 962, 850, 835, 805, 753, 693 cm -1 ; UV (CH 2 Cl 2 , c = 8.45 × 10 -5 )? (?) = 464 (8,380), 489 (11,000), 522 (9,050) nm; HRMS (FAB) calcd for C 30 H 32 S 2 456.1945, found 456.1945.
Claims (18)
- (a) 이소프렌으로부터 하기 구조식 D로 표시되는 클로로하이드린 화합물을 제조하는 단계; (a) preparing a chlorohydrin compound represented by the following structural formula D from isoprene;(b) 하기 구조식 D로 표시되는 화합물의 알릴릭 알콜의 브롬화 반응으로 하기 화학식 E로 표시되는 알릴릭디할라이드 화합물을 제조하는 단계; (b) brominating an allylic alcohol of the compound represented by the following structural formula D to produce an allyl-ylide halide compound represented by the following formula (E);(c) 하기 화학식 E로 표시되는 알릴릭디할라이드 화합물과 2-머켑토벤조티아졸을 반응시켜 하기 화학식 F로 표시되는 클로로알릴릭 설파이드 화합물을 제조하는 단계; (c) reacting an allyl halide compound represented by the formula (E) with 2-mercaptobenzothiazole to prepare a chloroallylic sulfide compound represented by the formula (F);(d) 하기 화학식 F로 표시되는 클로로알릴릭 설파이드 화합물의 산화반응에 의해 하기 화학식 G로 표시되는 클로로알릴릭 설폰 화합물을 제조하는 단계; 및 (d) preparing a chloroallylic sulfone compound represented by the following formula (G) by oxidation reaction of a chloroallylic sulfide compound represented by the following formula (F); And(e) 하기 화학식 G로 표시되는 화합물의 알릴릭 클로라이드와 트리에틸포스파이트 [P(OEt)3]와의 아르부조프(Arbuzov) 반응에 의하여 디에틸 포스포네이트기를 생성하는 단계를 포함하여 구성되는 하기 구조식 5로 표시되는 디에틸 (4-(벤조[d]티아졸-2-일설포닐)-2-메틸-2-부텐-1-일)포스포네이트의 제조방법.(e) producing a diethylphosphonate group by Arbuzov reaction of allylic chloride of the compound represented by the formula (G) with triethylphosphite [P (OEt) 3 ] A process for producing diethyl (4- (benzo [ d ] thiazole-2-ylsulfonyl) -2-methyl-2-buten-1-yl) phosphonate represented by the following structural formula 5.[구조식 D][Structural formula D][구조식 E][Structural formula E][구조식 F][Structural formula F][구조식 G][Structural formula G][구조식 5][Structural Formula 5]
- 청구항 3에 있어서,The method of claim 3,상기 (c)단계에서 상기 구조식 E로 표시되는 알릴릭디할라이드 화합물과 2-머켑토벤조티아졸은 1:1의 당량비로 반응시키는 것을 특징으로 하는 상기 구조식 5로 표시되는 디에틸 (4-(벤조[d]티아졸-2-일설포닐)-2-메틸-2-부텐-1-일)포스포네이트의 제조방법.Wherein the allyl halide compound represented by the structural formula E and the 2-mercaptobenzothiazole are reacted in an equivalent ratio of 1: 1 in the step (c) [ d ] thiazole-2-ylsulfonyl) -2-methyl-2-buten-1-yl) phosphonate.
- 하기 구조식 5로 표시되는 디에틸 (4-(벤조[d]티아졸-2-일설포닐)-2-메틸-2-부텐-1-일)포스포네이트와 하기 구조식 4로 표시되는 2,7-디메틸-2,4,6-옥타트리엔디알을 반응시켜 하기 구조식 2로 표시되는 테트라에틸 (2,6,11,15-테트라메틸헥사데카-2,4,6,8,10,12,14-헵타엔-1,16-디일)비스(포스포네이트)를 제조하는 방법.(4- (benzo [ d ] thiazole-2-ylsulfonyl) -2-methyl-2-buten-1-yl) phosphonate represented by the following structural formula 5 and 2,7 -Dimethyl-2,4,6-octatriendial are reacted to obtain tetraethyl (2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12, 14-heptaen-1,16-diyl) bis (phosphonate).[구조식 5][Structural Formula 5][구조식 4][Structural Formula 4][구조식 2][Structural formula 2]
- 청구항 5에서 있어서,The method of claim 5,상기 구조식 5로 표시되는 디에틸 (4-(벤조[d]티아졸-2-일설포닐)-2-메틸-2-부텐-1-일)포스포네이트와 상기 구조식 4로 표시되는 2,7-디메틸-2,4,6-옥타트리엔디알은 2:1의 당량비로 반응시키는 것을 특징으로 하는 상기 구조식 2로 표시되는 테트라에틸 (2,6,11,15-테트라메틸헥사데카-2,4,6,8,10,12,14-헵타엔-1,16-디일)비스(포스포네이트)를 제조하는 방법.(Benzo [ d ] thiazole-2-ylsulfonyl) -2-methyl-2-buten-1-yl) phosphonate represented by the structural formula 5 and 2,7 (2,6,11,15-tetramethylhexadec-2-ene) represented by the structural formula 2, which is reacted at an equivalent ratio of 2: 1 to dimethyl-2,4,6- Heptaen-1,16-diyl) bis (phosphonate).
- 하기 구조식 2로 표시되는 C20 폴리엔 비스(포스포네이트) 화합물과 하기 구조식 A로 표시되는 알데하이드 화합물을 반응시켜 하기 구조식 1로 표시되는 카로틴 화합물을 제조하는 방법. Reacting a C 20 polyenbis (phosphonate) compound represented by the following structural formula 2 with an aldehyde compound represented by the following structural formula A to produce a carotene compound represented by the following structural formula 1.[구조식 2][Structural formula 2][구조식 A][Structural Formula A]상기 구조식 A에서 R은 탄소수 5 내지 20 사이의 알킬, 아릴, 아르알킬(aralkyl), 및 헤테로아릴로 이루어진 군으로부터 선택될 수 있다. In Formula A above, R may be selected from the group consisting of alkyl, aryl, aralkyl, and heteroaryl having 5 to 20 carbon atoms.[구조식 1][Structural formula 1]상기 구조식 1에서 R은 탄소수 5 내지 20 사이의 알킬, 아릴, 아르알킬(aralkyl), 및 헤테로아릴로 이루어진 군으로부터 선택될 수 있다. In Formula 1, R may be selected from the group consisting of alkyl, aryl, aralkyl, and heteroaryl having 5 to 20 carbon atoms.
- 청구항 7에 있어서,The method of claim 7,상기 구조식 2로 표시되는 C20 폴리엔 비스(포스포네이트) 화합물과 상기 구조식 A로 표시되는 알데하이드 화합물은 1:2의 당량비로 반응시키는 것을 특징으로 하는 상기 구조식 1로 표시되는 카로틴 화합물을 제조하는 방법. Wherein the carotene compound represented by Formula 1 is prepared by reacting a C 20 polyenbis (phosphonate) compound represented by Formula 2 with an aldehyde compound represented by Formula A in an equivalent ratio of 1: 2 Way.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180010221A KR102092655B1 (en) | 2018-01-26 | 2018-01-26 | C20 polyene bis(phosphonate) and method for synthesizing carotenoids using the same |
KR10-2018-0010221 | 2018-01-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019147015A1 true WO2019147015A1 (en) | 2019-08-01 |
Family
ID=67394770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2019/000964 WO2019147015A1 (en) | 2018-01-26 | 2019-01-23 | Efficient synthesis method of c20 polyene bis(phosphonate) and carotene compound using same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102092655B1 (en) |
WO (1) | WO2019147015A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112321421A (en) * | 2020-09-29 | 2021-02-05 | 宿迁科思化学有限公司 | Preparation method of 1-acetoxyl-4-chloro-3-methyl-2-butene |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2551914A1 (en) * | 1975-11-19 | 1977-06-02 | Hoechst Ag | Symmetrical carotenoids prodn. - by oxidising polyene triphenyl-phosphine-ylids with singlet oxygen; pref. with triphenyl phosphite-ozone adduct |
KR20050077504A (en) * | 2001-10-31 | 2005-08-02 | 구상호 | Method of preparing di(4-chloro-3-methyl-2-butenyl) sulfone for synthesis of natural carotenoid products |
KR100733023B1 (en) * | 2006-06-05 | 2007-06-28 | 구상호 | Dialdehyde compound, preparation method thereof, and synthetic method of carotenoids using the same |
-
2018
- 2018-01-26 KR KR1020180010221A patent/KR102092655B1/en active IP Right Grant
-
2019
- 2019-01-23 WO PCT/KR2019/000964 patent/WO2019147015A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2551914A1 (en) * | 1975-11-19 | 1977-06-02 | Hoechst Ag | Symmetrical carotenoids prodn. - by oxidising polyene triphenyl-phosphine-ylids with singlet oxygen; pref. with triphenyl phosphite-ozone adduct |
KR20050077504A (en) * | 2001-10-31 | 2005-08-02 | 구상호 | Method of preparing di(4-chloro-3-methyl-2-butenyl) sulfone for synthesis of natural carotenoid products |
KR100733023B1 (en) * | 2006-06-05 | 2007-06-28 | 구상호 | Dialdehyde compound, preparation method thereof, and synthetic method of carotenoids using the same |
Non-Patent Citations (3)
Title |
---|
EFFENBERGER, F.: "Synthesen endständig substituierter, konjugierter Polyene", SYNTHESIS, vol. 11, 1990, pages 1085 - 1094, XP055628935 * |
KIM, D.: "Fast Assembly and High-Throughput Screening of Structure and Antioxidant Relationship of Carotenoids", ORGANIC LETTERS, vol. 21, no. 3, 16 January 2019 (2019-01-16), pages 714 - 718, XP055628938 * |
KIM, M.: "Role of Ring Ortho Substituents on the Configuration of Carotenoid Polyene Chains", ORGANIC LETTERS, vol. 20, no. 2, 10 January 2018 (2018-01-10), pages 493 - 496, XP055628937 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112321421A (en) * | 2020-09-29 | 2021-02-05 | 宿迁科思化学有限公司 | Preparation method of 1-acetoxyl-4-chloro-3-methyl-2-butene |
Also Published As
Publication number | Publication date |
---|---|
KR20190091139A (en) | 2019-08-05 |
KR102092655B1 (en) | 2020-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Marino et al. | The enantioselective synthesis of (-)-physostigmine via chiral sulfoxides | |
Detty | Oxidation of selenides and tellurides with positive halogenating species | |
US4831152A (en) | 5-halo-6-nitro-2-substituted benzoxazole compounds | |
KR960002273B1 (en) | 6,7-substituted-8-alkoxy-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinoline | |
WO2019147015A1 (en) | Efficient synthesis method of c20 polyene bis(phosphonate) and carotene compound using same | |
WO2017126847A1 (en) | Method for preparing 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofurane-2-yl) propanol derivative, and intermediate therefor | |
CN115073495B (en) | Indoline compound and preparation method thereof | |
WO2012050315A2 (en) | Azetidinium salt as fp-cit precursor, method for selectively preparing same, and fp-cit synthesis | |
NO158673B (en) | ANALOGY PROCEDURES FOR THE PREPARATION OF THERAPEUTIC ACTIVE AZUREND DERIVATIVES. | |
EP0302195B1 (en) | Process for the preparation of naphthacenes | |
WO2014017797A1 (en) | Novel method for preparing 1-oxacephalosporin derivative | |
Han et al. | l-Proline catalyzed condensation–cyclization tandem process: Facile and effective synthesis of 3-polyfluoroalkanesulfonyl coumarin | |
WO2015053576A1 (en) | Method for preparation of 3-alkylthio-2-bromopyridine | |
KR102434471B1 (en) | Posaconazole, composition, intermediate, preparation method therefor, and uses thereof | |
WO2016076573A2 (en) | Method for preparing blonanserin and intermediate therefor | |
Mukaiyama et al. | Syntheses and Reactions of 2-Ethylthio-or 2-Phenylthio-2-cycloalkenones | |
WO2011105649A1 (en) | New method for manufacturing pitavastatin hemicalcium using new intermediate | |
KR20050121258A (en) | Process for the production of 9-cis retinoic acid | |
US6433176B1 (en) | Method for making 8-hydroxyjulolidine compound | |
Bose et al. | Studies on Lactams. II. 1 A Simplified Synthesis | |
JPH0748376A (en) | Production of 1h-pyrrolo-(1,2-b)(1,2,4)triazole derivative | |
KR0131050B1 (en) | Novel amine compounds and process preparing thereof | |
WO2013172687A1 (en) | Novel statin intermediate, and production method for pitavastatin, rosuvastatin, cerivastatin and fluvastatin using same | |
JPS5869856A (en) | Preparation of 2-alkoxyiminobutyric acid derivative | |
WO2021107646A1 (en) | Method for producing maxacalcitol, and intermediate therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19743307 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19743307 Country of ref document: EP Kind code of ref document: A1 |